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RESUME 
 
Choriorétinopathie séreuse centrale : Etude de l’évolution à long terme au moyen de 
l’angiographie au vert d’indocyanine 
 
Nous avons analysé les altérations de la circulation choroïdienne au moyen de l’angiographie 
au vert d’indocyanine (angiographie-ICG) chez les patients atteints d’une choriorétinopathie séreuse 
centrale (CSC), pour décrire leur évolution à long terme. 
L’étude fut portée sur 22 yeux de 20 patients, 16 hommes et 4 femmes de 45,6±5,2 ans. 
Les patients furent suivis pendant 33,1±18,3 mois avec des examens réguliers, y compris des 
angiographies-ICG. Trois groupes furent étudiés, correspondant aux formes aiguë, chronique, et 
cicatricielle. 
L’angiographie-ICG a démontré une hyperperméabilité anormale des choriocapillaires dans 
des régions actives et non-actives, souvent associée à des décollements de l’épithélium pigmentaire 
(EP). Cette hyperperméabilité serait à l’origine des altérations de la CSC. Il s’agit de lésions 
évolutives à long terme, pouvant entraîner des altérations permanentes de l’EP et des 
photorécepteurs, telles que décompensation diffuse de l’EP, cicatrices multiples et plages 
atrophiques. Ceci expliquerait la diminution de l’acuité visuelle finale retrouvée dans le groupe CSC-
chronique. 
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INTRODUCTION 
 
La choriorétinopathie séreuse centrale (CSC) est une maladie classiquement décrite comme 
une atteinte aiguë, caractérisée par un décollement séreux de la rétine en région maculaire, 
affectant de préférence des hommes jeunes (85%) dont l’âge se situe entre 20 et 50 ans [1,2]. 
Aucun cas de CSC n’a été rapporté avant l’âge de 20 ans. Chez les patients dont l’âge est supérieur 
à 50 ans, la CSC peut également survenir, mais il est alors difficile de la distinguer d’une 
dégénérescence maculaire liée à l’âge. L’atteinte est principalement unilatérale, une présentation 
bilatérale et symétrique de cette maladie n’ayant été rapportée que chez 10% des patients. Des 
récidives ont été documentées dans 50% des cas ou plus [1,2]. Cette atteinte est principalement 
observée chez des individus de coefficient intellectuel élevé, exerçant des tâches exigeant une 
bonne vision, et qui expriment une personnalité de type A ou encore, subissent un stress physique 
ou émotionnel [3]. Une anamnèse de maux de tête de type migraine peut également être retrouvée 
[1,4]. En outre, la CSC a été associée à des agents vasoconstricteurs [5], à l’hypercortisolisme 
endogène [6] et à l’administration systémique de corticostéroïdes [7]. Elle peut être induite chez 
des animaux au moyen d’injections intraveineuses répétées d’épinephrine (adrénaline) [5]. 
Bien qu’une métamorphopsie unilatérale soit le symptôme classique de la CSC, les patients 
peuvent également présenter une vision trouble unilatérale, une micropsie, une perturbation de 
l’adaptation à l’obscurité, une désaturation aux couleurs, un temps prolongé de rétablissement de la 
rétine à la lumière intense, ainsi qu’un scotome relatif. L’acuité visuelle se trouve habituellement 
améliorée avec une correction hypermétropique. Les symptômes caractéristiquement régressent en 
quelques mois, mais ils peuvent réapparaître, même après la résorption du liquide. Dans de très 
rares cas, ils persistent définitivement. Lorsque les séquelles de la CSC sont permanentes, elles 
incluent une métamorphopsie, une perception diminuée de l’intensité de la lumière, ainsi qu’une 
vision des couleurs altérée [1,4]. 
En outre, la CSC peut se présenter comme un décollement rétinien bulleux, en périphérie 
inférieure, non-rhégmatogène. La présence de bandes atrophiques de l’épithélium pigmentaire 
(EP), visualisées à l’angiographie fluorescéinique, et qui s’étendent de la région maculaire jusqu’au 
décollement périphérique, confirme le diagnostic ainsi que la source du liquide sous-rétinien [8]. 
Une forme chronique de CSC existe également [9]. Dans environ 5% des cas, une 
épithéliopathie rétinienne diffuse se développe en liaison avec la présence persistante ou 
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intermittente de liquide sous-rétinien [10]. Les décollements rétiniens tendent à devenir plus 
superficiels et plus diffus par rapport à ceux de la forme classique. Le pronostic visuel est alors 
moins bon [11]. 
 
Le diagnostic de la CSC est posé au niveau clinique et confirmé avec une angiographie 
fluorescéinique [1,4]. Bien que, dans la plupart des cas, le diagnostic puisse être aisément posé 
sans examen auxiliaire, les informations fournies par l’angiographie fluorescéinique sont 
déterminantes pour évaluer l’étendu des lésions rétiniennes et pour exclure la présence d’une autre 
pathologie, telle qu’une membrane néovasculaire choroïdienne, une fossette colobomateuse de la 
papille, un mélanome choroïdien, une métastase choroïdienne, un hémangiome choroïdien, une 
uvéite, une maladie de Harada, une neuropathie optique, un œdème papillaire, une traction 
vitréenne, etc. 
L’angiographie fluorescéinique nous a également procuré les premiers éléments de la 
pathogenèse de la CSC, en permettant de détecter la diffusion du produit de contraste à travers 
une anomalie de l’EP. Malgré la possibilité de poser le diagnostic et d’identifier une ou plusieurs 
anomalies ou altérations de l’EP avec l’angiographie fluorescéinique, il n’est pas possible de clarifier 
le rôle exact de l’EP et de la vasculature choroïdienne dans cette maladie, en raison de l’effet 
masque de l’EP. 
L’utilisation d’une nouvelle substance fluorescente, du vert d’indocyanine (ICG), durant les 20 
dernières années, nous a permis d’observer et d’enregistrer des images de la choroïde [12,13]. 
L’ICG est un colorant tricarbocyanide, présentant un pic d’absorption à 805 nm et une émission de 
fluorescence proche de l’infrarouge (835 nm) [12,16]. Comme l’EP n’absorbe que 10% de la 
radiation infrarouge utilisée dans l’angiographie au vert d’indocyanine (angiographie ICG) [17], 
cette technique a permis l’observation de lésions choroïdiennes dans la CSC qui échappent à 
l’angiographie fluorescéinique. 
 
Le but principal de notre étude est d’analyser les indications fournies par l’angiographie ICG, 
puis de les comparer avec les résultats des examens cliniques et fluoro-angiographiques effectués 
sur les yeux atteints et non-atteints d’une CSC, ceci nous permettant, dans un second temps, 
d’ajouter certains éléments susceptibles d’expliquer les mécanismes patho-physiologique et 
pathogénique de cette maladie. Ainsi que nous l’avons dit auparavant, l’utilisation de l’angiographie 
fluorescéinique ne nous permet pas d’investiguer le rôle de la choroïde dans le cours de cette 
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maladie. Grâce à l’angiographie ICG, nous tenterons de découvrir les altérations existant au niveau 
de la choroïde. 
L’objectif secondaire de cette étude est de décrire les résultats à long terme du suivi des 
patients atteints d’une CSC. Ces résultats concernent l’acuité visuelle en fonction des diverses 
formes de la maladie, du nombre de récidives, de l’évolution des altérations rétiniennes et de l’effet 
de l’administration de stéroïdes ou de la co-existence de maladies systémiques non-oculaires. 
 
Vingt patients consécutifs (22 yeux) atteints d’une CSC ont été inclus dans cette étude. Tous 
les patients ont subi un examen ophtalmologique complet incluant un examen fundoscopique, des 
photos couleur de la rétine, des angiographies fluorescéiniques et à l’ICG. Selon les caractéristiques 
cliniques et angiographiques, les patients ont été classifiés en trois groupes : CSC aiguë (15 
patients – 15 yeux), CSC chronique (3 patients – 5 yeux) et CSC inactive cicatricielle (2 patients – 2 
yeux). Le suivi moyen était de 33,1 mois (de 13 à 90 mois). 
Le groupe des patients était composé de 16 hommes et de 4 femmes. L’âge moyen (± SD) 
était de 45,6 ± 5,2 ans (de 35 à 56 ans). Une maladie systémique non-oculaire était présente chez 
35% des patients et une administration de stéroïdes a été documentée dans tous ces cas. A la fin 
du suivi, l’acuité visuelle corrigée était supérieure de manière statistiquement significative dans le 
groupe CSC aiguë par rapport au groupe CSC chronique (0,8 vs 0,3 respectivement). Malgré la 
détection d’un ou de plusieurs points de diffusion chez tous les patients avec CSC active au moyen 
de l’angiographie fluorescéinique, ces points n’étaient détectés que dans 46,6% des cas au moyen 
de l’angiographie ICG. A l’angiographie ICG, les yeux avec une CSC active présentaient une 
hyperfluorescence choroïdienne par imprégnation dans les régions actives et non-actives. En outre, 
cette imprégnation choroïdienne a été également observée dans l’œil adelphe malgré l’absence de 
signe de maladie active. Les mêmes résultats ont été obtenus dans les groupes CSC chronique et 
CSC inactive cicatricielle. 
L’utilisation de l’angiographie ICG à haute résolution, telle qu’elle est appliquée de nos jours 
dans l’investigation d’un grand nombre de maladies oculaires, nous a offert l’avantage d’investiguer 
en détail la vasculature choroïdienne. Une exsudation choroïdienne avait été signalée par plusieurs 
auteurs avant l’ère de l’angiographie ICG [18,19]. 
L’idée d’hyperperméabilité choroïdienne est considérée aujourd’hui comme une étape 
vraisemblable de la pathogenèse de la CSC, bien que cette théorie ne soit basée que sur les 
indications indirectes de l’angiographie ICG. La principale caractéristique, signalée par la majorité 
des auteurs, est la présence sur l’angiographie ICG de régions d’hyperfluorescence choroïdienne par 
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imprégnation [20-26]. Cette hyperfluorescence n’a pas été observée uniquement dans des régions 
actives, mais aussi dans des régions inactives et même dans l’œil contra-latéral qui ne présentait 
aucun signe de CSC active, ni cliniquement ni à l’angiographie fluorescéinique [21-27]. Ces régions 
d’hyperperméabilité choroïdienne présumée entourent des points de diffusion ou des décollements 
de l’EP ; cependant, elles sont également détectées en correspondance avec des régions d’atrophie 
de l’EP ou des zones sans altération fluoro-angiographique [23,24]. L’imprégnation choroïdienne 
reste inchangée [23,24] ou augmente [23,26] au cours du suivi, même lorsque l’exsudation sous-
rétinienne régresse. Il en découle que cette hyperperméabilité présumée des chorio-capillaires est 
une caractéristique importante de tous les stades de l’évolution de la CSC et apparaît comme 
l’altération primaire de la maladie [23,24]. En outre, certains auteurs soutiennent que cette 
hyperperméabilité localisée est probablement associée à une hypoperfusion choroïdienne par 
segments [23,24]. La nature récurrente de la diffusion du produit de contraste au niveau de la 
choroïde est probablement associée à une pathologie préalable et persistante dans l’espace sous-
rétinien. Cette activité chronique, qui n’est détectée ni par l’examen clinique, ni à l’angiographie 
fluorescéinique, est probablement à l’origine des récidives des décollements séreux de la rétine et 
des altérations de l’EP dans la CSC, en particulier dans ses formes sévères. 
Cette étude est purement clinique. Une probable limitation en serait l’absence de donnés 
expérimentaux, ce qui aurait soutenu les indications angiographiques concernant la pathogenèse de 
la CSC. Pourtant, l’aspect expérimental ne faisait pas partie du but de cette étude. En outre, malgré 
l’existence de nombreuses références bibliographiques pour une grande majorité de pathologies 
oculaires, la recherche de la littérature pour une CSC expérimentale n’a donné que de faibles 
résultats, provenant surtout de deux groupes de recherche [28-34]. En effet, le modèle proposé de 
CSC expérimentale, i.e par des injections répétées d’adrenaline en i.v, ne peut pas induire toute 
forme de CSC, est principalement un modèle de décollement séreux de la rétine centrale avec un 
EP périphérique sain, n’est pas chronique, et vise à examiner surtout les altérations histo-
pathologiques et les propriétés dynamiques des liquides choroïdien et rétinien en présence de 
défauts de l’EP. Pour ces raisons, ainsi que parce que nous avons voulu focaliser cette étude sur les 
anomalies liées à l’angiographie ICG chez les patients avec une CSC, nous avons décidé de ne pas 
inclure de donnés expérimentaux mais de présenter un cadre qui permettrait une analyse de 
synthèse sur le sujet de la pathogenèse de la CSC. 
Cette étude suggère que la CSC n’est pas une simple atteinte unilatérale, aiguë et auto-
délimitée, mais plus probablement une maladie chronique, susceptible de menacer la vision. En 
effet, chez certains patients, plus particulièrement lorsque la durée de la maladie est prolongée et 
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que des régions d’atrophie de l’EP confluentes se développent, la CSC se présente comme une 
pathologie qui menace la vision [21]. 
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1.1 ANATOMY OF THE RETINA. 
 
Gross anatomy of the retina. 
The retina is a delicate, diaphanous tissue that measures about 0.1 mm in thickness at the ora, 
0.2 mm at the equator, and 0.56 mm adjacent to the optic nerve head. The internal aspect of the 
retina is in contact with the vitreous body and its external aspect is adjacent to but separated from 
the RPE by a potential space, called the intraretinal space. Posteriorly, all retinal layers except the 
nerve fiber layer terminate at the optic nerve head. Peripherally, the sensory retina extends to the 
ora serrata, where it is continuous with the nonpigmented ciliary epithelium of the pars plana (see 
Fig.1 and 2). Although the retina conforms to the shape of the adjacent pigment epithelium and 
underlying sclera, it is firmly attached to the pigment epithelium in only two areas: the optic disc 
and the ora serrata. Attachments elsewhere are weak and subject to disruption due to relatively 
trivial forces. Attachments between vitreous and retina also occur. 
 
 
 
 
 
 
 
 
 
Fig.1 Sagittal section of eye with 
absent vitreous. Dimensions are 
approximate and are the average 
dimension in the normal adult eye. 
Major structures are identified. 
Fig.2 Peripheral retina from posterior, with lens 
removed. The termination of the retina (ora serrata) 
varies slightly in different processes of the peripheral 
retina (see text). The dentate processes of the retina 
extend anteriorly, and the bays of the pars plana 
extend posteriorly to create a serrated appearance. 
The insertions of the rectus muscles are close to the 
ora, as shown. SR, superior rectus; LR, lateral 
rectus; IR, inferior rectus; MR, medial rectus; T, 
temporal; N, nasal. 
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Central retina 
 
The central retina (area centralis) or macular region is defined histologically as that area of the 
posterior retina having at least two layers of nuclei in the ganglion cell layer. Grossly and clinically 
(ophthalmoscopically), the border of this area is less 
clearly defined. The fovea is a zone 1.5 mm in diameter 
centered about 4.0 mm temporal and 0.8 mm inferior to 
the center of the optic nerve head (see Fig.3). The inner 
retinal surface of the fovea is concave due to thinning of 
the inner retinal layers, the average retinal thickness of 
the fovea is about 0.25 mm, roughly half that of the adjacent posterior retina. The nerve fiber, 
ganglion cell, and inner plexiform layers are absent from the fovea. The inner nuclear layer is 
reduced to a double row of cells at the edge of the fovea and is absent within the fovea. The 
central 0.57-mm-diameter photoreceptor layer of the fovea is composed entirely of cones. Almost 
all of the blood vessels in this part of the retina are capillaries, and the central capillary-free zone in 
the macula is about 0.4 mm in diameter. 
The parafoveal central retina is about 0.5 mm in width and surrounds the fovea. It is 
characterized by the prominent cellularity of the inner retinal layers, especially the inner nuclear 
and ganglion cell layers. The nerve fiber layer is also relatively thick, especially in the so-called 
papillomacular bundle at the nasal margin. The cone-rod ratio is 1:1. 
 The perifoveal retina, 1.5 mm in width, is the peripheral zone of the macular region. It 
extends out about 2.75 mm from the center of the fovea where the ganglion cell layer is reduced to 
the single layer of nuclei seen elsewhere in the peripheral retina. The cone-rod ratio here is 1:2 
(see Fig.3). 
 
 
 
 
Fig.3 Clinical and correlated histopathologic views 
of the macular region. Fundus photographs shows 
foveola (a), fovea (b), parafoveal area (c), and 
perifoveal regions (d). 
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Peripheral retina 
 
The peripheral retina gradually becomes attenuated as it approaches the ora serrata, where it 
terminates and becomes continuous with the nonpigmented epithelium of the pars plana. The ora 
serrata measures 2.1 mm in width temporally and 0.7 to 0.8 mm nasally. The term ora serrata 
refers to the serrated appearance of this zone, with so-called dentate processes, or teeth, 
encroaching anteriorly on the pars plana of the ciliary body, and intervening bays that represent 
posterior extensions of the pars plana (see Fig. 1,2). The greatest number of dentate processes and 
bays is found in the superonasal quadrant, with a progressive decrease in number in the 
inferonasal, superotemporal, and inferotemporal quadrants. 
 
Morphology of the retina  
The general features of retinal histology are well known from classic works by Ramσn y Cajal 
[1], Polyak [2], and, more recently, Hogan et al [3]. Recent advancements in electron microscopy, 
immunocytochemistry, and intracellular horseradish peroxidase (HRP) injections have helped 
determine the synaptic connections within the retina and have led to a better understanding of the 
functional architecture of the retina. The neurons of the retina are divided into three layers: (1) the 
most external (the outer, or scleral, layer) is the photoreceptor cell layer, which includes the outer 
and inner segments and the layer of photoreceptor cell bodies (or outer nuclear layer), (2) the layer 
of intermediate neurons (or inner nuclear layer), and (3) the layer of ganglion cells. The synapses 
are confined to the two synaptic, or plexiform, layers--the outer and inner plexiform layers. A light 
micrograph of a monkey retina illustrates the organization of the primate retina (see Fig. 4). 
 The receptor layer of the retina is intimately apposed to the pigment epithelium; light rays 
Fig.4 Light micrograph of a section through a 
monkey retina stained with a modified silver 
stain. The following cellular and synaptic layers 
are shown: ILM, inner limiting membrane; NFL, 
nerve fiber layer; GCL, ganglion cell layer; IPL, 
inner plexiform layer; INL, inner nuclear layer 
consisting of nuclei of interneurons (amacrine, 
bipolar, and horizontal cells) and Mόller cells 
(M), the major glial cell of the retina; OPL, outer 
plexiform layer; ONL, outer nuclear layer (nuclei 
of photoreceptor cells); ELM, external limiting 
membrane; IS, inner segments of photoreceptor 
cells; OS, outer segments of photoreceptor cells; 
RPE, retinal pigment epithelium; CC, 
choriocapillaris. Note that cone photoreceptors 
(C) are scattered but more prominent than the 
numerous, thin rod photoreceptor cells. (x 475.) 
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pass through the ganglion cells and inner layers to reach the photoreceptor cells, where light is 
transformed into an electrochemical event. The elongated axonal processes of the photoreceptor 
cells synapse in the outer plexiform layer with the processes of the bipolar cells and horizontal cells, 
whose cell bodies are located in the inner nuclear layer. The horizontal cells form a means of lateral 
communication between photoreceptor cells, among which they send processes. The bipolar cells 
synapse with amacrine or ganglion cells, or both. Amacrine cells are located primarily in the vitreal 
portion of the inner nuclear layer. They extend processes to adjacent amacrine or bipolar cells, and 
their axons synapse with ganglion cells. The axons of ganglion cells converge to form the nerve 
fiber layer and exit the eye as the optic nerve. 
Another cell type, whose perikarya are located among the amacrine cell perikarya, is the inner 
plexiform cell. Unlike amacrine cells, however, the inner plexiform cells extend processes into both 
synaptic layers. The various retinal cell types and their connections are presented in Fig. 5. 
 
The external (outer) limiting membrane is formed by junctional complexes between cell 
membranes of the major glial cells, the Müller cells, and photoreceptor inner segments. The internal 
(inner) limiting membrane consists of a basement membrane, which is actually a surface 
modification of the vitreous body, and the expanded vitreal processes of Müller cells. Within the 
retina, fine processes of Müller cells envelop, at least partially, all the neurons. These processes 
extend laterally from the main portion of the Müller cells, which extend from the external to the 
internal limiting membranes as radial fibers. 
 
Fig.5  Schematic diagram of cell types and histologic 
layers in the human retina. Retinal layers are labeled as 
in Fig. 4. Also shown are Bruch's membrane 
(considered as the innermost layer of the choroid, but 
in fact the basement membrane of the RPE) and the 
edge of the vitreous. The basic relationship between 
rod (R) and cone (C) photoreceptors as well as bipolar 
(B), horizontal (H), amacrine (Am), inner plexiform 
cell (I), displaced amacrine (DA), and ganglion (G) 
neurons is depicted. Note that the Müller cell (M) 
extends almost the width of the retina; the apical 
processes of the Müller cell form the external limiting 
membrane (ELM), while the foot processes of the 
Müller cell partially form the inner limiting membrane 
(ILM). Astrocytes (As) are found primarily in the 
nerve fiber layer (NFL). 
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1.2 CIRCULATION OF THE RETINA 
 
The retinal circulation is the complex of arteries, veins, and capillaries emanating from the optic 
nerve head and supplying the inner retina from the inner nuclear layer to the optic nerve fiber layer 
[4]. Fig. 6 is a fluorescein angiogram of a subhuman primate that has had the temporal choroidal 
arteries excised.  
 
The background choroidal fluorescence has 
thus been eliminated from the macular area 
demonstrating the arterioles, capillaries, and 
venules of the retinal circulation. The central 
retinal artery and its branches lie nasal to the 
central retinal vein in the nerve head. The 
arteries are more narrow and straight than the corresponding veins. The retinal vessels are 
extremely variable in number and position but follow a general pattern of supero- and inferonasal 
and supero- and inferotemporal positions. The nasal vessels radiate from the nerve head; the 
temporal vessels arch above and below the macula in company with the arcuate nerve fibers. Small 
vessels, called cilioretinal vessels, may pass directly toward the macula from the temporal margin of 
the nerve head. The arteries lie over the veins where arteriovenous crossings occur. The large 
vessels lie in the innermost portion of the retina, separated from the internal limiting membrane by 
a thin process of glia. Large vessels may penetrate into the retina to the inner plexiform layer, but 
only capillaries are found in the inner nuclear layer. The primary capillary beds of the retina are in 
the nerve fiber-ganglion cell layers and in the inner nuclear layer [5]. An additional capillary 
network is found in the most superficial nerve fiber layer in the distribution of the arcuate nerve 
fibers; this capillary network extends closely around the nerve head [6]. This is the network of 
radial peripapillary capillaries, which seem designed to nourish the retinal nerve fibers that 
accumulate into an increasingly thicker nerve fiber layer as the nerve head is approached. 
Fig. 6 Fluorescein angiogram in a subhuman 
primate that has had the temporal short posterior 
ciliary artery branches excised. The retinal 
arterioles, capillaries, and venules are seen in the 
temporal half of the retina. 
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 Fig. 7 is a normal fluorescein angiogram demonstrating the macular area containing the 
fovea. The capillary-free zone is approximately 400 mm in diameter.  
 
Capillaries are also absent near the retinal arteries and 
arterioles. The concentration of capillaries increases as 
the distance increases from the arteries, with the 
concentration of capillaries greatest adjacent to the 
retinal veins (see Fig. 8). This difference in capillary 
density results in a constant oxygen tension across the 
retina with the exception of the areas immediately surrounding the retinal arteries where the 
oxygen tension is exceptionally high [7]. As the distance from the artery increases and oxygen 
decreases in the blood, the concentration of capillaries increases so that tissue oxygen remains 
constant. 
 
  
 
 
 
The retinal circulation is at a relatively high pressure 
with the feeding ophthalmic artery at the same pressure 
as the common carotid artery [8]. The pressure in the 
veins is also high within the eye, as it must be higher than the intraocular pressure in order for the 
blood to exit the eye. Arterioles and venules cross one another in the retina and indeed may be 
compromised here by relative constrictions. The retina is vulnerable to branch obstructions and 
devastated by occlusion of its single feeding central retinal artery. 
 
AUTOREGULATION 
Blood flow, in general, is regulated by the autonomic nervous system, but an exception is the 
retinal vasculature. The ophthalmic artery is richly innervated with adrenergic fibers until the lamina 
Fig. 7 Normal fluorescein angiogram demonstrating the 
capillary free zone around the fovea. The background 
choroidal fluorescence is blocked by the xanthophyll 
Fig.8. Latex- and pigment-filled retinal 
vasculature demonstrating the increase in 
the density of the capillaries beginning 
adjacent to the arteriole in the center of the 
photograph. There are venules above and 
below that are surrounded by capillaries. 
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cribrosa is reached. From this point on, however, it is devoid of sympathetic fibers; thus, there is no 
nervous system control of the retinal circulation within the eye [9]. 
 The process of autoregulation in a vascular tree results in maintenance of a constant blood 
flow in the presence of a variable perfusion pressure. The perfusion pressure of retinal vessels is 
the difference between intravascular pressure (blood pressure) and intraocular pressure. Tissue 
homeostasis requires a controlled blood flow, and non-nervous autoregulatory mechanisms 
controlling the retinal vasculature accomplish this [10-12]. The effector organ of autoregulation is 
smooth muscle whose tone controls vessel diameter and blood flow. One intrinsic factor that is 
known to affect blood flow is tissue oxygen tension. Elevated blood oxygen tension results in 
vasoconstriction, and a decrease of the oxygen tension below normal causes vasodilation [13-15]. 
The retinal vasoconstriction is probably due to high retinal arterial oxygen tension, but there is also 
a flooding of the retina with oxygen from the choroidal circulation. 
 Autoregulatory responses are triggered by acute changes in perfusion pressure and elevated 
intraocular pressure results in vasodilation. Intraocular pressure can be experimentally manipulated 
and an example of autoregulation can be seen with occlusion of a retinal venule by 
photocoagulation. There is an acute elevation in peripheral resistance and then immediate 
constriction of the feeding arteriole [7]. This myogenic constriction eventually relaxes, and the 
vessel dilates, presumably in response to the accumulation of metabolic by-products such as carbon 
dioxide accompanied by a decrease in pH. 
These and other studies have clearly demonstrated the presence of efficient retinal 
autoregulation which adjusts retinal blood flow and tissue oxygenation to changes in retinal 
perfusion pressure and oxygen tension. The outer retina has a relatively high metabolic activity 
which increases in the dark during the regeneration of the visual pigments. It is interesting to note 
that retinal blood flow increases in the dark-adapted eye, presumably in response to the increased 
metabolic demand [10,16,17]. 
 Failure of the blood-flow autoregulation is an important component of many retinal vascular 
diseases. It commonly occurs very early in the evolution of pathologic processes that affect the 
circulation such as diabetes and systemic hypertension. Normal vascular reactivity undergoes a 
gradual decrease with age, and some retinal vascular diseases show an accelerated course in the 
elderly. Senescent changes in vascular reactivity may complicate evaluation of patients when subtle 
early changes are sought as evidence of a developing disease process [18] 
 The permeability of the retinal blood vessels is important because there is a barrier between 
the circulation and the retina [19] The physical barriers are due to tight junctions between the cells 
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of the retinal vasculature as well as between retinal pigment epithelial cells. The latter is necessary 
because the choriocapillaris is fenestrated and relatively permeable. The barriers are important 
because they keep circulating substances that would hinder retinal function out of the tissue and 
presumably inhibit the movement of neural transmitters out of the retina. Because of these barriers, 
carriers are necessary for nutrients which are required in high concentration by the metabolically 
active retina [20].  
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1.3  ANATOMY OF THE THE CHOROID 
 
The choroid is a distinct component of the uveal tissue within the globe. Forming the 
posteriormost portion of the uveal tract, the choroid lies between the external sclera and the 
internal retinal pigment epithelium and retina. It has the highest blood flow of any structure in the 
human body, including the brain and kidneys [21].  The structure of the choroid is organized into 
layers reflecting the specialized requirements of nutritional support for the outer retina [22],  
providing light-adsorbing pigment to improve visual resolution, assisting in the regulation of 
intraocular pressure, and providing thermal stabilization of the globe [23].  An understanding of 
choroidal function must consider the highly refined anatomic, cellular, and molecular organization 
that begins with development and progresses throughout development and life. 
EMBRYOLOGY 
The events in the formation of the choroid occur primarily within the first trimester. The choroid 
is composed of cells of neuroectodermal and mesodermal origins that have migrated from the 
neural crest [24-26]. During the sixth and seventh months melanocytes derived from neural crest 
cells develop and pigment the choroid, beginning posteriorly and continuing anteriorly [26].  By the 
ninth month the choriocapillaris is fully developed and the choroid is complete. 
ANATOMY 
The choroid is a highly vascularized and pigmented layer located between the retinal pigment 
epithelium and the sclera that comprises the posterior portion of the uvea (Fig. 9). 
It is approximately 0.2 mm thick posteriorly, 
tapering to 0.10 to 0.15 mm thick in the periphery. The 
inner aspect of the choroid is limited by Bruch's 
membrane, which with the choroid is itself a 
multilaminated structure. Bruch's membrane is tightly bound to the underlying choriocapillaris and 
forms the boundary between the retinal pigment epithelium and the choroid. The innermost 
choroidal layer next to Bruch's membrane is the choriocapillaris; the middle layer is composed of 
medium-sized vessels (Sattler's layer) and the outer layer of larger vessels (Haller's layer). These 
layers are most clearly outlined posteriorly. The choriocapillaris extends from the optic nerve to the 
Fig.9  Normal human adult choroid at the posterior 
pole. a)Bruch’s layer (large arrowheads), 
b)choriocapillaris (small arrowheads), c) Sattler’s 
layer (thin arrows), and d)Haller’s layer (thick arrows) 
are indicated. (Photonic Microscopy, PM) 
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ora serrata anteriorly. Between the choroid and the sclera is the suprachoroidal or perichoroidal 
space. Because of this potential space the choroid and sclera can be easily separated.  
 
Suprachoroidal Space 
This zone is multilaminar and comprises the outer 30 µm between the choroid and the sclera 
[27]. The collagen layers of the suprachoroid number between six and ten and are avascular, 
except for the vessels that penetrate it traversing from the choroid through to the sclera. Within 
this area are crisscrossing collagen fibers that loosely bind the two structures together, oriented 
outward and posteriorly inserting into the sclera [27]. The suprachoroid is heavily pigmented owing 
to the high numbers of melanocytes [27].   
 
Haller's Layer 
Haller's layer is composed of the outer vessels of the choroid. The vessels are large-diameter 
arteries and veins with many melanocytes, ciliary nerves, and scattered clusters of nevus cells. 
These arteries are similar to those of the rest of the body, having an outer adventitial layer, a 
smooth muscle layer comprising the media, and an internal elastic layer [27,28]. The vessels of the 
outer layers of the choroid are not fenestrated and therefore do not leak fluorescein dye during 
angiography. 
 
Sattler's Layer 
Sattler's layer is the center of the choroid and is composed of medium-sized vessels with 
prominent melanocytes, macrophages, lymphocytes, mast and plasma cells, and fibroblasts. Within 
Sattler's layer the transition from arteries to arterioles is accomplished. As the caliber of the arteries 
diminishes they gradually lose the muscularis layer (media) and the internal elastic lamina. The 
adventitia gradually becomes the outer collagenous fibers [27,28].  The vessels of Sattler's layer are 
not fenestrated and so, in a fashion similar to Haller's layer, do not leak fluorescein dye during 
angiography.  
 
Choriocapillaris 
The choriocapillaris is formed by a monolayer of capillaries immediately next to Bruch's 
membrane. The capillaries are large, measuring between 25 and 50 µm in diameter [29].  The size 
of the lumen permits several erythrocytes to pass through simultaneously. The capillaries are 
fenestrated, with most of the fenestrations located on the side of the retinal pigment epithelium.  
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These fenestrations (60–80 nm in diameter) are permeable to fluorescein dye and leak during the 
angiogram. The choriocapillaris extends from the immediate peripapillary region to the ora serrata 
anteriorly. The 
juxtapapillary border 
of the choriocapillaris 
exhibits an end-
capillary organization 
and contains clear, 
abrupt ends of the 
capillaries, as well as 
arterioloarteriolar and 
arteriolovenular 
anastomoses. From the arterioles, which appear as a third dichotomous division of the short 
posterior ciliary arteries, branches of the arterioles with average internal (i.e., blood stream size) 
diameter of 25 µm are forwarded around the juxtapapillary margin toward the prelaminar part of 
the lamina cribrosa (Fig. 10).  
These branches are found in the 360-degree area of the juxtapapillary choriocapillaris margin, 
with a slightly higher representation in the temporal as opposed to the nasal side (six to seven 
branches and five branches, respectively), as well as a much smaller representation from the 
inferior and superior part of the optic nerve head (one to three branches). These branches supply 
blood to the prelaminar part of the optic nerve head in a segmental fashion and form part of the 
capillary network in this area [30].  
When viewed from the anterior (retinal side), the peripapillary choriocapillaris has a dense 
honeycomb, monolayer arrangement without any apparent divisions into  “lobuli” (Fig. 12). The 
feeding arterioles and collecting venules reach the posterior face of the choriocapillaris in the 
peripapillary area, forming a 90-degree angle.  
Fig. 10 Vascular cast of the peripapillary choroid from a 
9-year-old rhesus monkey (posteriorview).  
Communication of the arterioles to the prelaminar 
vascular supply of the lamina cribrosa (arrows).  
ON, Optic nerve; LC, lamina cribrosa; CH, choroid;  
a, arteriole; v, venule. (Scanning Electron 
Microscopy,SEM)  
Fig. 11  Vascular cast of the distal human 
optic nerve (ON), the lamina cribrosa 
region (LC), and the peripapillary 
choroid (CH) viewed from above in a 46-
year-old man.  
Short posterior ciliary artery (SPCA). 
Scleral arterial circle of Zinn-Haller (Z-
H). Recurrent pial branches from the 
scleral portion of the SPCA (large 
arrows) anastomose with 
 the pial vessels of the optic nerve. 
Recurrent choroidal branches to the 
lamina cribrosa (small arrows). (SEM) 
 34
 
This same arrangement of the choriocapillaris, arterioles, and 
venules is present in the submacular area. However, in this 
area the ratio of the feeding arterioles to collecting venules is 
3:1, and in addition to this, several arterioloarteriolar 
anastomoses are observed.  
 
The submacular area is fed by 8 to 16 centripetal branches from the tertiary choroidal arteries, 
in turn branches of the short posterior ciliary arteries that penetrate the sclera posteriorly [31]. A 
garland of large choroidal arteries, located within Haller's layer, surrounds the macular region. 
These arteries have a radial arrangement and continue their course toward the choroidal periphery. 
The posterior pole has a more  “lobular” arrangement [29,32-37]. The choriocapillaris 
monolayer becomes much looser in appearance, and because of this capillary structure the venules 
and arterioles can reach the plane of the capillaries and branch at this level. Two different kinds of 
openings exist for the feeding arterioles and collecting venules in this region; some arteriolar and 
venular openings are at 90 degrees to the choriocapillaris, and some arborize at the capillary level 
(Fig. 13). 
  Recent detailed descriptions of the choroidal 
anatomy suggest that there is no unified rule for the 
distribution of the feeding arterioles and collecting 
venules in the lobuli at the posterior pole [37].  
Examination of the lobular structure revealed that 
Fig. 12 Peripapillary choroid from a 62-year-old man 
(temporal part, anterior view). Dense choriocapillaris network 
with no lobular delineation. Openings of feeding arterioles(a) 
and collecting venule (v). (SEM)  
Fig.13  Choroid from rhesus monkey (posterior view, 
posterior pole). Collecting venules located 90 
degrees to the choriocapillaris (o) in plane (X). Major 
arteriolar openings (open arrows), which are in the 
center of choroidal units (CH). Additional arteriolar 
 openings located on periphery of lobuli 
(arrowheads). Lobuli outlined by broken 
lines.Vascular cast. a, Arteriole; v, venule. (SEM) 
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venules are usually found in the lobuli center with the feeding arterioles located within the lobular 
periphery, but reversals of this pattern are occasionally seen (Figs. 14 and 15).   
  
 
 
 
 
   Major feeding arterioles are noted to have openings in a centrifugal fashion with connections to a 
few surrounding lobuli. This suggests that such arterioles are supplying a few lobuli instead of 
merely one. Therefore the use of the term choroidal unit may be more appropriately used in 
respect to describing the choroidal microcirculation. Such choroidal units in the monkey measure 
700 to 800 µm. A study by Olver  [29] supports previous observations [29]  that the choroidal 
circulation is not truly end arterial since there are potential collaterals and recovery from acute 
choroidal ischemia may be rapid and spontaneous. 
Several intervascular channels are noted at different levels of the choroid. These interarterial, 
intervenous, interarteriolar, intervenular, and arteriolovenular anastomoses are seen across the 
choroid (Figs. 16 and 17).  
 
 
Fig.15 The equatorial area of the choriocapillaris 
from a 20-year-old man (anterior view).  Between 
the lobuli are regular vascular dilations (curved 
arrows) of unknown function. Vascular cast. (SEM) 
Fig. 16  Anastomoses between an arteriole and a venule in 
the choroid of a 7-year-old rhesus 
monkey (posterior view). Endothelial cell indentations 
(arrows) are spindle shaped. 
They elongate in the arteriole (A), and they are round or 
oval in the venule (V). Vascular cast. (SEM) 
Fig.14 The choroidal equatorial area of a 55-year-old man 
(posterior view). Distribution of the collecting venules (v), 
feeding arterioles (a), and their openings in the 
choriocapillaris (CH). Arteriolar openings (arrows) are 
mostly located at the periphery of lobules (broken lines 
delineate lobules). Vascular cast. (SEM) 
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 In elder cases, sclerotic vascular changes create 
arteriovenous crossing phenomena, which are 
consistently observed over the choroidal larger 
vessels (Fig. 17). 
  Electron microscopy of the choriocapillaris reveals 
the capillaries to be surrounded by a basement membrane. Pericytes are occasionally located within 
the basement membrane in the external wall of the capillaries, but the capillary is not fully invested 
by pericytes [28].  Endothelial cells have both tight junction and gap junctions, with the former 
being described as discontinuous and variably placed and the latter primarily located on the scleral 
side of the capillary [28]. 
 
Bruch's Membrane 
Bruch's membrane is the inner layer of the choroids. The structure of Bruch's membrane is 
composed of five layers; the basal lamina (lamina lucida and lamina densa) or basement membrane 
of the retinal pigment epithelial cells, the inner collagen layer, the elastic layer, the outer collagen 
layer, and the basal lamina (lamina lucida and lamina densa) or basement membrane of the 
choriocapillaris. These layered connective tissue sheets are permeable to the fluorescein molecule. 
Bruch's membrane is thickest at the posterior pole and around the optic nerve (2–4 µm) and 
narrows peripherally (1–2 µm) [27,28].  
 
 
 
 
 
 
 
Fig.17  Equatorial choriocapillaris from a 68-year-old 
woman (posterior view). Venules make 
 perpendicular connections with choriocapillaris (CH). 
Note elongated openings of both arteriole and venule 
in the plane of the choriocapillaris (X). Intervenular 
anastomosis (open arrow). Arteriolovenular crossings 
form the so-called bulbiculi (arrows). Vascular cast. A, 
Arteriole; v, venule; o, venular openings. (SEM) 
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1.4 CIRCULATION AND PHYSIOLOGY 
The retina receives a disproportionate amount of its metabolic support from the choroid relative 
to the intrinsic retinal vessels. Retinal oxygenation originates 65 percent from the choroid and 35 
percent from the retinal circulation [21]. Ensuring adequate oxygenation and metabolic support for 
the outer retina while maintaining unobstructed vision at the fovea is the primary function of the 
choroid. Thus, the choroidal organization permits minimal vascularity of the inner retina, enhancing 
its optical properties, with the disadvantage that the outer retina has to receive its metabolic 
support from a more remote location. 
The pattern of blood flow in the choroid has several unique features. The rate of blood flow in 
the choroid is approximately ten times the flow of the brain [22]  and four times the flow in the 
kidney [21,38]. When the total blood supply to the eye is considered, 85 percent is distributed to 
the choroid and 4 percent is distributed to the retina (10 percent to the ciliary body and 1 percent 
to the iris) [21,39,40]. 
 
Choroidal Macrocirculation 
The blood to the larger vessels of the choroid originates from the first branch of the internal 
carotid artery, the ophthalmic artery. The medial and lateral long posterior ciliary arteries arise from 
the ophthalmic artery; less frequently a superior long posterior ciliary artery is found [32]. These 
ciliary arteries enter the sclera with the long ciliary nerves 3 to 4 mm anterior to the optic nerve 
[27]. They then proceed in the suprachoroidal space anteriorly, reach the ciliary body, and finally 
end in the major arterial circle of the iris.  
Before entering the sclera, the long posterior ciliary arteries give rise to 15 to 20 branches—
short posterior ciliary arteries—that enter the sclera 2 to 2.5 mm from the optic nerve. These short 
posterior ciliary arteries are clustered primarily in two groups in the horizontal meridian on either 
side of the optic nerve. Secondary and tertiary branches of these short ciliary arteries subsequently 
divide into the major choroidal arteries. The choroidal arteries supply the choriocapillaris from the 
optic nerve to the ora serrata. The short posterior ciliary arteries contribute paraoptic branches to 
the Zinn-Haller circle as well as pial branches. They provide segmental supply to the lamina 
cribrosa, retrolaminar optic nerve, and optic disc [29,34,37].  
The venous drainage of the choroid is by four to seven vortex veins (98 percent of globes have 
six vortex veins) distributed among the four quadrants of the globe. Some drainage occurs through 
the anterior ciliary veins of the ciliary body. Blood exits the lobules of the choriocapillaris by 
collecting venules that join the afferent veins; these in turn connect to the ampulla of the vortex 
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veins, and blood is then conducted by the respective vortex vein through the sclera. The vortex 
veins are located 2.5 to 3 mm posterior to the equator, closer to the vertical meridian than to the 
horizontal, and drain into the superior and inferior orbital veins [41]  
Choroidal Microcirculation 
Clearly the large rate of flow in the capillary bed of the choroid is due both to the large caliber 
of the vascular lumen and the low resistance to blood-flow [22]. The pattern of blood supply in the 
choriocapillaris has been the subject of discussion in recent years [29,32,35-37]. Early reports on 
the choroid and choriocapillaris based on vascular injection studies described the capillary bed as a 
continuous network with extensive anastomoses. These studies suggested that occlusion of one 
choroidal arteriole would not compromise the vascularization of the choriocapillaris. Clinical and 
experimental data did not support this conclusion, since induced choroidal ischemia tends to have a 
segmental, geographic pattern not consistent with alternative flow through rich anastomotic 
channels. In vivo fluorescein angiography studies confirmed that the pattern of blood supply is one 
of segmental end-arteriole circulation with no functional contribution by arterial anastomotic 
avenues [32]. The anastomoses, however, may play a role in the regulation of flow in 
nonphysiologic events, such as when the blood flow or perfusion pressure is markedly reduced in 
adjacent lobules as occurs in periods of ischemia [29,34,37].  
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METABOLISM AND REGULATION OF CHOROIDAL BLOOD FLOW 
In contrast to the blood-retinal barrier, maintained by the tight junctions of both the retinal 
vascular endothelium and pigment epithelium, the choroid is freely accessible to low molecular 
weight proteins and other molecules within the blood, as typified by the fluorescein dye used during 
angiography. This important difference is responsible for the creation of a large oncotic pressure in 
the choroid relative to the retina [42] as well as for maintaining an abundance of nutrient materials 
available for the metabolic needs of the outer retinal layers [43] 
As discussed earlier, the choroidal blood supply is one of the highest of any organ in the body. 
The reason for this is not well understood. Suggestions in the literature include retinal 
thermoregulation by removal of heat generated during visual transduction [23], fluid removal from 
the retinal outer layers by the high choroidal oncotic pressure, or subserving the metabolic needs of 
the retina even during periods of total ischemia [22].  
Above all considerations is the necessity to provide to the photoreceptor/retinal pigment 
epithelium complex the oxygen, nutrition, and raw materials required by the visual transduction 
machinery [22]. Through the fenestrations of the choroid, proteins and other substances of high 
molecular weight enter the interstitial spaces of the choroid; in this way retinol-binding protein as 
well as vitamin A become available to the retinal pigment epithelial cells for transport to the outer 
layers of the retina [22]. 
The movement of these metabolites and nutrients takes place across both the retinal pigment 
epithelium and Bruch's membrane. Both active and passive transport mechanisms facilitate the 
movement of selected molecules across the blood-retina barrier [44] into the retina and of waste 
products and water out of the retina. Bruch's membrane poses no barrier to the movement of these 
nutrients except in aging, when permeability changes due to lipoprotein accumulation from rod 
outer segment degradation may obstruct the movement of water from the retinal pigment 
epithelium to the choroid [22,45] 
The ability of the choroid to autoregulate its blood flow is a matter of debate [22,46]  as is 
choroidal vasodilation to increased PCO2  [22,46,47].  The high volume of choroidal blood flow and 
negligible loss of nutrients and metabolites provide little reason for autoregulation within the 
choroid. The choroidal blood flow seems to be regulated by the autonomic nervous system [46,48] 
through the presence of b-adrenergic receptors on the choroidal vessels [49]  This is important in 
diseases such as diabetes and hypertension, in which autonomic control is altered [50].  
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1.5 THE RETINAL PIGMENT EPITHELIUM–STRUCTURE AND              
      SPECIALIZED FUNCTIONS. 
 
Given their strategic location between the photoreceptors and the choriocapillaris, the 
importance of the retinal pigment epithelium (RPE) and the interphotoreceptor matrix (IPM) in the 
normal functioning and health of the retina cannot be overemphasized. While seemingly simple in 
appearance, the RPE cells have developed a complex structural and functional polarity that allows 
them to perform highly specialized roles, and the IPM represents a complex array of soluble and 
insoluble components, the functions of which are just now being elucidated.  
 
RETINAL PIGMENT EPITHELIUM 
Morphologic and cytoplasmic specialization 
RPE cells in the adult have a highly specialized internal and external organization, including 
both morphologic and functional polarity. Typical features of these cells are their polygonal shape, 
tight junctions, apical microvilli, and basal membrane infoldings (Fig. 18). 
 
 
 
Internally, in addition to organelles involved in 
"housekeeping" functions, RPE cells also have 
organelles related to their distinctive functions. 
Melanin granules, which are thought to increase photoreceptor efficiency by absorbing scattered 
light, require the expression of specific enzymes for the synthesis of melanin from tyrosine and 
dopa. Phagosomes and phagolysosomes are involved in the degradation of phagocytosed outer 
segment material.  
 Two of the best known functions of the RPE cells, their involvement in photoreceptor outer 
segment renewal and in retinol uptake and transport, are prime examples of morphologic and 
Fig.19 Diagrammatic representation of a 
section through a retinal pigment epithelial 
cell. A, microvilli; B, photoreceptor outer 
segment; C, interphotoreceptor matrix; D, 
melanin granule; E, phagosome; F, 
lysosome; G, tight junction; H, basal plasma 
membrane infoldings; I, RPE basement 
membrane; J, Bruch's membrane; K, 
choroidal capillary basement membrane; L, 
phagolysosome. 
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biochemical membrane specializations indicative of cellular polarization. Tight junctions appear to 
be important in a number of RPE functions, including their role in the blood-retinal barrier, as well 
as the sequestration of molecules into apical and basal plasma membrane domains. Some of these 
molecules are responsible for the vectorial transport of nutrients from the choroid to the outer 
retina and the removal of wastes, water, and ions in the opposite direction.  
 
Some functional considerations 
The blood-retinal barrier and transport 
The positioning of the RPE between the outer retina and the choriocapillaris, as well as the 
presence of the junctional complex between RPE cells, imposes upon this cell layer the important 
role of selectively transporting nutrients from the choroidal circulation to the outer retina. The tight 
junctions prevent the diffusion of even small molecules, and metabolites required by the outer 
retina must therefore be exchanged across the RPE cells themselves. Such exchanges are facilitated 
by elaborate basal plasma membrane infoldings and an array of apical microvilli which serve to 
increase surface area for the exchange of nutrients and wastes [51]. In addition to these 
morphologic specializations, receptors for molecules arriving from the choriocapillaris would be 
expected to be present on the basolateral surfaces of the RPE. 
The best-characterized example of transport in the RPE is that of retinal [52,53]. 
Phagocytosis of shed outer segments 
One of the most extensively studied functions of RPE cells is their role in the internalization and 
subsequent degradation of outer segment fragments which are shed daily from the distal end of the 
photoreceptors.  
Phagocytosis of shed outer segment fragments includes an initial recognition phase involving 
their binding to the RPE apical microvilli which are interdigitated with photoreceptor outer 
segments. Binding is followed by invagination of the plasma membrane around the outer segment 
fragment, leading to its ingestion into a phagosome [54].  
Na+,K+,- ATPase 
Contrary to the situation in most epithelial cells in which ATPase is predominantly localized in 
the basal plasma membrane, the enzyme is confined to the apical plasma membrane of RPE cells 
[55,56]. This polarization appears to be established fairly early in development, and follows a 
spatial and temporal pattern similar to the central-to-peripheral maturation pattern exhibited by the 
developing neural retina [57].  
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From this apical localization, Na+,K+-ATPase controls the flux of sodium and potassium ions 
across the plasma membrane, thereby maintaining the proper balance of these ions in the 
interphotoreceptor matrix and establishing membrane potentials [58,59]  
Extracellular matrix production 
RPE cells actively synthesize extracellular matrix (ECM) molecules and systematically degrade 
them in processes, which, if abnormal, can lead to RPE abnormalities [60 
Retinal attachment 
While the mechanisms involved in the attachment of RPE cells to their basement membrane 
and the adhesive interactions between cells within the retina (especially during development) are 
fairly well understood, the mechanism(s) involved in the "attachment" of the retina to the RPE 
remains much more controversial. Particularly relevant to this chapter is the hypothetical function of 
the IPM as a "glue."  
 Another confounding issue has been that the IPM is conspicuously poor in molecular factors 
normally associated with cell attachment, such as collagen [61,62] fibronectin [61,62], NCAM [63] 
and the high-molecular-weight isoform of laminin [64]. However, it has been recently demonstrated 
that the IPM of mature retinas from several animals, including mammalian species, contains s-
laminin, a homologue of the B1 chain of laminin [64].  
It has become fairly clear in recent years, however, that the insoluble photoreceptor-associated 
domains of the IPM play an important role in maintaining physical associations between 
photoreceptors and the RPE. These unique extracellular domains, which reach from the surface of 
the retina to the RPE, are ideally situated to mediate attachment that would not involve direct 
interactions between the plasma membranes of retinal and RPE cells. Evidence for the involvement 
of these structures comes from several sources [65,66]. 
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2.1 FLUORESCEIN ANGIOGRAPHY. 
 
Definition 
  • An imaging test that highlights the retinal and choroidal circulation and is useful in the diagnosis 
of retinal, choroidal, and optic nerve disorders. Progression of various disease entities and 
treatment decisions, as well as guidance during laser treatment, often are based on fluorescein 
angiography. 
  • Common diseases for which fluorescein angiography is used in routine management are: 
diabetic retinopathy, choroidal neovascularization, cystoid macular edema, central serous 
chorioretinopathy and venous occlusive disease. 
 
Introduction 
For the past 25 years, fundus photography and fluorescein angiography have proved to be 
extremely valuable techniques for expanding our knowledge of the pathologic anatomy and 
pathophysiology of various conditions, and have aided the diagnosis and monitoring of the 
treatment of retinal vascular and macular diseases. Initially, fluorescein angiography was used 
primarily as a laboratory and clinical research tool; only later was it used for diagnosis of fundus 
diseases [1,2]. Although it now fulfills many roles, fluorescein angiography is most often used as a 
guide to laser treatment of fundus diseases and as a means of evaluating that treatment. Any 
ophthalmologist who sees patients with retinal problems must understand fluorescein angiography. 
Further, those ophthalmologists who treat patients with retinal vascular and macular disease must 
be able to interpret fluorescein angiograms. 
 The first part of this chapter discusses the basic principles of fluorescein angiography and 
the equipment and techniques needed to produce a high-quality angiogram. Potential side effects 
and complications of fluorescein injection are also discussed. The second part focuses on the 
interpretation of fluorescein angiography, including fundus anatomy and histology, the normal 
fluorescein angiogram, and abnormal fundus fluorescence. 
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BASIC PRINCIPLES 
To understand fluorescein angiography, one must have a knowledge of fluorescence. Likewise, 
to understand fluorescence, one must know the principles of luminescence. 
 Luminescence is the emission of light from any source other than high temperature. 
Luminescence occurs when energy in the form of electromagnetic radiation is absorbed and then 
re-emitted at another frequency. When light energy is absorbed into a luminescent material, free 
electrons are elevated into higher energy states. This energy is then re-emitted by spontaneous 
decay of the electrons into their lower energy states. When this decay occurs in the visible 
spectrum, it is called luminescence. Luminescence, therefore, always entails a shift from a shorter 
wavelength to a longer wavelength. The shorter wavelengths represent higher energy; the longer 
wavelengths, lower energy. 
 Fluorescence is luminescence that is maintained only by continuous excitation. In other 
words, excitation at one wavelength occurs and is emitted immediately through a longer 
wavelength. Emissions stops at once when the excitation stops. Fluorescence thus does not have 
an afterglow. A typical example of fluorescence is television. In the television tube, the excitation 
radiation is the electron beam from the cathode-ray tube. This beam excites the phosphors of the 
screen, which reemit the beam as a glow that constitutes a television picture. 
 Sodium fluorescein is a hydrocarbon that responds to light energy between 465 and 490 nm 
and will fluoresce at a wavelength of 520 to 530 nm. The excitation wavelength, the type that is 
absorbed and changed, is blue; the resultant fluorescence, or emitted wavelength, is green-yellow. 
If blue light at 465 to 490 nm is directed to unbound sodium fluorescein, it will emit a light that 
appears green-yellow (520-530 nm) [3]. 
 This principle is central to fluorescein angiography. In the procedure the patient, whose eyes 
have been dilated, is seated behind the fundus camera on which a blue filter has been placed in 
front of the flash. Fluorescein is then injected intravenously. Eighty percent of the fluorescein 
become bound to protein and is not available for fluorescence, but 20% remains free in the 
bloodstream and is available for fluorescence. The blue flash of the fundus camera excites the 
unbound fluorescein within the blood vessels or the fluorescein that has leaked out of the blood 
vessels. The blue filter shields out (reflects or absorbs) all other light and allows through only the 
blue excitation light. The blue light then changes those structures in the eye containing fluorescein 
to green-yellow light at 520 to 530 nm [3-5]. In addition, blue light is reflected off of fundus 
structures that do not contain fluorescein. The blue reflected light and the green-yellow fluorescent 
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light are directed back toward the film of the fundus camera. Just in front of the film a filter is 
placed that allows the green-yellow fluorescent light through but keeps out the blue reflected light. 
Therefore the only light that penetrates the filter is true fluorescent light (Fig.1). 
 
 Pseudo-fluorescence occurs when 
non-fluorescent light passes through the 
entire filter system [3,5]. If green-yellow 
light penetrates the original blue filter, it 
will pass through the entire system. If 
blue light reflected from non-fluorescent 
fundus structures penetrates the green-yellow filter, pseudo-fluorescence will occur (Fig. 2). 
Because fluorescein angiography is done with black-and-white film, the non-fluorescent or pseudo-
fluorescent light appears as a background illumination. Pseudo-fluorescence, i.e., fake fluorescence, 
causes non-fluorescent structures to appear fluorescent. It can confuse the physician interpreting 
the fluorescein angiogram and lead him or her to think that certain fundus structures or materials 
are fluorescing when they are not. Pseudo-fluorescence also causes decreased contrast, as well as 
decreased resolution. The background illumination from pseudo-fluorescence is especially 
heightened if there are white areas of the fundus, such as highly reflective, hard exudates. It is 
important that pseudo-fluorescence be avoided. 
Therefore the excitation (blue) and barrier 
(green-yellow) filters should be carefully matched 
so that there is a minimal overlap of light 
between them [3]. 
 
 
Fig.1  Absorption and emission curves 
of sodium fluorescein dye. The peak 
absorption (excitation) is at 465 to 490 
nm (blue light). The peak emission 
occurs at 420 to 430 nm (yellow-green 
light). 
Fig.2 Pseudofluorescence. The blue exciter 
filter overlaps into the yellow-green zone, 
and the yellow-green barrier filter overlaps 
into the blue zone. The combination results 
in pseudofluorescence. 
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 Sodium fluorescein, the orange-red crystalline hydrocarbon (C20H12O5Na), has a low 
molecular weight (376.27 daltons) and readily diffuses through most of the body fluids and through 
the choriocapillaris, but it does not diffuse through the retinal vascular endothelium or the pigment 
epithelium [6,17]. Fluorescein is eliminated by the liver and kidneys within 24 hours, although 
traces may be found in the body for up to a week after injection. Retention may be increased if 
renal function is impaired. The skin will have a yellowish tinge for a few hours following injection, 
and the urine takes on a characteristic yellow-orange color for most of the first day following 
injection. 
EQUIPMENT 
Because fluorescein angiography is a highly technical form of ophthalmic photography, it 
requires sophisticated equipment [5,7]. The equipment and materials needed for angiography are 
the following: 
1. Fundus camera and auxillary equipment. 
2. Two camera backs (one with a motor drive and a timer). 
3. Matched fluorescein filters (barrier and exciter). 
4. 35-mm black-and-white film. 
5. 35-mm color film. 
6. 23-gauge scalp-vein needle. 
7. 5-mL syringe. 
8. 5 mL of 10% fluorescein solution. 
9. 20-gauge, 1 1/2-in. needle to draw the dye. 
10. Armrest for fluorescein injection. 
11. Tourniquet. 
12. Alcohol swabs. 
13. Bandage. 
14. Standard emergency equipment. 
 
Checklist for fluorescein angiography [5,7]. 
 
1. Inform patient about fluorescein angiography. Obtain verbal or written informed 
consent. 
2. Dilate patient's pupils. 
3. Prepare fluorescein solution, scalp-vein needle, and syringe. 
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4. Prepare fundus camera: 
a. Clean front lens. 
b. Load color and black-and-white film into two camera backs. 
c. Focus eyepiece cross hairs. 
5. Take identification photograph, which includes patient's name, the date, and  
other data (number of fluorescein angiogram, patient's vision of right eye and left 
eye, referring physician, etc.). 
6. Position patient for alignment, focus, and comfort. 
7. Align and focus camera. 
8. Complete color photography. 
9. Switch to camera with black-and-white film for fluorescein photography. 
10. Take red-free photographs (Frames 2-5). 
11. Insert scalp-vein needle. 
12. Simultaneously start timer from zero and inject fluorescein dye. 
13. Take preinjection color photographs; shoot at exact start of injection as timer is   
turned on and shoot second shot at exact finish of injection (length of time of 
injection is automatically recorded). 
14. Start fluorescein photography 8 seconds after the start of injection in young    
          patients and 12 seconds in older patients. 
15. Follow fluorescein angiography plan. 
15. When photography is done, reassure patient that all went well and remind him or  
her that the urine will be discolored for a day or so. Have patient wait an additional 20 
minutes for observation for possible reactions to fluorescein. 
 Finally, it is not only very useful but actually both essential and extremely cost-effective for 
the physician to indicate specifically what areas of each or which fundus to photograph. The 
photographer should be directed as to where to start the angiogram and what other areas to 
photograph. He or she should know all of the issues that are important for each specific angiogram. 
Color film and its processing are extremely expensive, so it is important for the photographer to 
know exactly how many color slides to take of each area. It is most convenient to use a 
photographic request slip that indicates the specific number of color photographs to take of each 
area, where to start the angiogram, what the diagnosis is, and any other information about the 
patient or fundus that is pertinent to the photographic process. 
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SIDE EFFECTS AND COMPLICATIONS. 
 Various side effects and complications can occur with fluorescein injection [8-12]. The 
prepared physician will have at hand the equipment necessary to manage these problems. 
 A serious complication of fluorescein injection is extravasation of the fluorescein under the 
skin. This can be extremely painful and may result in a number of uncomfortable symptoms. 
Necrosis and sloughing of the skin may occur, although this is extremely rare [10]. Superficial 
phlebitis has also been noted. A subcutaneous granuloma has occurred in a few patients after 
fluorescein extravasation. In each instance, however, the granuloma has been small, cosmetically 
invisible, and painless. Toxic neuritis caused by infiltration of extravasated fluorescein along a nerve 
in the antecubital area can result in considerable pain for up to a few hours. The application of an 
ice pack at the site of extravasation may help relieve pain. For extremely painful reactions an 
injection of a local anesthetic at the site of extravasation is very effective but rarely necessary. 
 When extravasation occurs, the physician must decide whether or not to continue 
angiography. Extravasation may occur immediately, and thus the serum concentration of the 
fluorescein will be insufficient for angiography. In this case it is usually best to place the needle in 
another vein and reinject a full dose of fluorescein, starting the process again from the beginning. 
Occasionally only a small amount of fluorescein is extravasated at the end of the injection. In this 
case photography can continue without stopping or reinjecting. A list of the major side effects and 
complications of fluorescein injection is presented below. 
Side effects and complications of fluorescein injection 
Extravasation and local tissue necrosis.  
 Inadvertent arterial injection.  
 Nausea.  
 Vomiting.  
 Vasovagal reaction (circulatory shock, myocardial infarction). 
 Allergic reaction, anaphylaxis (hives and itching, respiratory 
 problems, laryngeal edema, bronchospasm). 
 Nerve palsy.  
 Neurologic problems (tonic-clonic seizures). 
 Thrombophlebitis.  
 Pyrexia.  
 Death. 
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It is always important to watch for extravasation at the beginning of the injection so that, 
should it occur, the process can be halted; thus only a minimal amount of fluorescein will have 
been injected and extravasated. The amount of extravasated fluorescein can be minimized by slow 
injection and constant observation of the needle with a handheld light or if injection is done before 
turning off the room lights. 
Nausea is the most frequent side effect of fluorescein injection, occurring in about 5% of 
patients. It is most likely to occur in patients under 50 years of age or when fluorescein is injected 
rapidly [11]. When nausea occurs, it usually begins approximately 30 seconds after injection, lasts 
for 2 to 3 minutes, and disappears slowly [11]. 
Vomiting occurs infrequently, in only 0.3% to 0.4% of patients [13]. When it does occur, it 
usually occurs 40 to 50 seconds after injection. By this time most of the initial-transit photographs 
of the angiogram will have been taken. A receptacle and tissues should be available in case 
vomiting does occur. When patients experience nausea or vomiting, they should be reassured that 
the unpleasant and uncomfortable feeling will subside rapidly. Photographs can be taken after the 
vomiting episode has passed. A slower, more gradual injection may help to avoid vomiting. 
 Patients who have experienced nausea or vomiting from fluorescein injection in the past may 
be given 25 or 50 mg of promethazine hydrochloride (Phenergan) by mouth approximately 1 hour 
before injection [11,13]. Promethazine has proved to be helpful in preventing or lessening the 
severity of nausea or vomiting. We have recently found that we can also reduce the incidence of 
nausea by warming the vial of fluorescein to body temperature and drawing it into the syringe 
through a needle with a Millipore filter. Restriction of food and water for 4 hours before fluorescein 
injection may reduce the incidence of vomiting; an empty stomach may prevent vomiting but will 
not affect nausea. If the patient still has a tendency to vomit despite taking all these measures, a 
lesser amount of fluorescein can be given and injected more slowly if the photographic results will 
not be compromised. 
 Vasovagal attacks occur much less frequently during fluorescein angiography than does 
nausea and are probably caused more by patient anxiety than by the actual injection of fluorescein. 
We have even seen vasovagal attacks when the patient sees the needle or immediately after the 
skin has been penetrated by the needle but before the injection has begun. Occasionally a 
vasovagal reaction will cause a patient to faint, but consciousness is regained within a few minutes.  
  If early symptoms of a vasovagal episode are noted, smelling salts will usually reverse the 
reaction.  
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 The photographer must be alert for clues of fainting because the patient could be injured if he 
falls. 
  Shock and syncope (more severe vasovagal reaction) consists of bradycardia, hypotension, 
reduced cardiovascular perfusion, sweating, and the sense of feeling cold. 
 If the photographer and person injecting see that the patient is getting "shocky" and 
lightheaded, the patient should be allowed to bend over or lie down with the feet elevated. The 
patient's blood pressure and pulse should be carefully monitored. 
 It is important to differentiate this from anaphylaxis, in which hypotension, tachycardia, 
bronchospasm, hives, and itching occur. 
 Hives and itching are the most frequent allergic reactions, usually occurring 2 to 15 minutes 
after the fluorescein injection. Although hives usually disappears within a few hours, an 
antihistamine such as diphenhydramine hydrochloride (Benadryl) may be administered 
intravenously for an immediate response. Bronchospasm and even anaphylaxis are other reactions 
that have been reported, but these are extremely rare. Epinephrine, systemic steroids, 
aminophylline, and pressor agents should be available to treat bronchospasm or any other allergic 
or anaphylactic reactions. Other equipment that should be readily available in the event of a severe 
vasovagal or anaphylactic reaction are oxygen, a sphygmomanometer, a stethoscope, and a device 
to provide an airway. The skilled photographer observes each patient carefully and is alert to any 
scratching, wheezing, or difficulty in breathing that the patient may experience after injection. 
There are a few published and unpublished reports of death following intravenous fluorescein 
injection. The mechanism may be a severe allergic reaction or a hypotensive episode induced by a 
vasovagal reaction in a patient with preexisting cardiac or cerebral vascular disease. The cause of 
death in each case may have been coincidental. Acute pulmonary edema following fluorescein 
injection has also been reported [13]. 
There are no known contraindications to fluorescein injections in patients with a history of heart 
disease, cardiac arrhythmia, or cardiac pacemakers [7]. Although there have been no reports of 
fetal complications from fluorescein injection during pregnancy, it is current practice to avoid 
angiography in women who are pregnant, especially in the first trimester [14,15]. 
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NORMAL FLUORESCEIN ANGIOGRAPHY 
The normal fluorescein angiogram is distinguished by certain specific characteristics [16]. 
Knowledge of these characteristics provides an essential frame of reference for interpreting 
abnormal fluorescein angiograms. 
 In the normal fluorescein angiogram (Fig.3), the first true fluorescence begins to show in the 
choroid approximately 10 to 12 seconds after injection in young patients (e.g., adolescents) and 12 
to 15 seconds after injection in older patients. Fluorescence can appear even earlier than 8 seconds 
in very young patients.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The choroid occasionally begins to fluoresce 1 or 2 seconds before the initial filling of the 
central retinal artery (Fig.4). Early choroidal fluorescence is faint, patchy, and irregularly scattered 
throughout the posterior fundus. It is interspersed with scattered islands of delayed fluorescein 
Fig.3  Normal fluorescein angiogram of right disc and macula taken with a 30-degree camera. A, Red-
free photograph shows normal macula, fovea, and retinal vessels. B, Early arterial phase of fluorescein 
angiogram. Note the ground-glass fluorescence of the choriocapillaris. The retinal arteries are filling with 
fluorescein. There is very little fluorescence in any of the retinal veins. C, Fluorescein angiogram 1 
second later. The retinal arteries and capillaries have filled, and the retinal veins are beginning to fill. 
Note the laminar flow in the retinal veins (arrows); the laminar flow is indicated by a white line of 
fluorescence along the walls of the retinal veins. D, One or 2 seconds later. Note that the laminar 
fluorescence in the veins has become so thick as to almost completely fill the veins with fluorescein. The 
dark hypofluorescent line in the veins (arrow) represents blood flow that is not yet fluorescent; it is 
coming from the periphery and takes longer to fluoresce. Note the very fine capillaries around the 
perifoveal capillary net. Note the dark macula. E, Mid- to late-arteriovenous-phase fluorescein 
angiogram (this photograph was taken approximately 3 minutes after fluorescein was injected). Note that 
the ground-glass fluorescence from the choriocapillaris has faded. Dark lines in the choroid are choroidal 
vessels seen in silhouette against the sclera, which is beginning to stain with fluorescein. The 
fluorescence of the retinal vessels has diminished markedly. F, Later arteriovenous-phase fluorescein 
angiogram. Note the faded fluorescence from the choroid and retinal vessels. The edge of the optic disc 
begins to stain with fluorescein. G, Very late-phase fluorescein angiogram. The disc stains with 
fluorescein, as does the sclera in the papillomacular bundle. The retinal vessels are only barely 
fluorescent. This photograph was taken approximately 15 minutes after fluorescein injection. 
A C D 
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Fig.4  Normal fluorescein angiogram of right disc and macula taken with a 60-degree camera. 
A, Red-free photograph. The disc and macula are normal. The reflex above and below the 
foveal area is normally seen in a young patient. B, The ground-glass fluorescence is the very 
early fluorescein filling of the choroid--the choroidal flush--which often occurs a few seconds 
before fluorescence within the retinal arteries, which in this photograph are just beginning to fill 
with fluorescein. C, Early arterial phase of angiogram. Note that the retinal arteries are filling, 
and the retinal veins have not yet begun to fluoresce. The choroid is almost completely 
fluorescent. The dark patches are areas of hypofluorescent choroid that have not yet received 
fluorescein; this is called patchy choroidal filling. D, Early arteriovenous phase of the 
angiogram. The retinal veins have begun to show fluorescein filling, as evidenced by the 
laminar flow within the veins. The patchy choroidal filling has mostly cleared, although still 
remaining are two patches faintly evident above the disc, one large patch below, and one 
filling. This early phase is referred to as the choroidal flush. When adjacent areas of choroidal filling 
and nonfilling are quite distinct, the pattern is designated as patchy choroidal filling. 
  
 
 
 
 
 
 
 
 
 
 
 
     
Within the next 10 seconds (approximately 20-25 seconds after injection), the angiogram becomes 
very bright for about 5 seconds because of the extreme choroidal fluorescence. Choroidal 
fluorescence, however, is not visible in the macular because of the taller, more pigmented pigment 
epithelium present in the fovea (retina). Therefore the macular remains dark throughout the 
angiogram. 
 If a cilioretinal artery is present, it usually begins to fluoresces as the choroid fluoresces 
rather than as the retina fluoresces. Within 1 to 3 seconds after choroidal fluorescence is visible, or 
approximately 10 to 15 seconds after injection, the central retinal artery begins to fluoresce. The 
less dense the concentration of pigment in the pigment epithelium, the greater the time will be 
between the visibility of the choroidal fluorescence and the filling of the retinal vessels. The lighter 
pigment presents less interference with choroidal fluorescence, allowing it to be evidence earlier in 
A B C 
D E F 
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its filling phase. With a more densely pigmented pigment epithelium, the blockage-barrier effect is 
greater. Therefore choroidal fluorescence appears somewhat later because a greater concentration 
of fluorescein is required to overcome the increased density of the pigment epithelial barrier. 
 Because no barrier exists in front of the retinal vessels, the patient's pigmentation has no 
effect on the visibility of the retinal vessels, although the degree of pigmentation does affect the 
contrast of the angiophotographs. The darker the pigment epithelium, the less visible the choroidal 
fluorescence will be and the greater the contrast of the retinal vascular fluorescence; i.e., the better 
they stand out. The lighter the pigment epithelium, the more visible the choroidal fluorescence will 
be and the less the contrast of the fluorescence from the retinal vessels. 
 After the central retinal artery begins to fill, the fluorescein flows into the retinal arteries, 
then into the precapillary arterioles, the capillaries, the postcapillary venules, and finally the retinal 
veins. Because the fluorescein from the venules enters the veins along their walls, the flow of 
fluorescein in the veins is laminar. Because vascular flow is faster in the center of a lumen (tube) 
than on the sides, the fluorescein seems to stick to the sides, creating the laminar pattern of retinal 
venous flow. The dark (nonfluorescent) central lamina is nonfluorescent blood that comes from the 
periphery, which takes longer to fluoresce because of its more distant location. 
 In the next 5 to 10 seconds fluorescence of the two parallel laminae along the walls of the 
retinal veins becomes thicker. At the junction of two veins the inner lamina of each vein may 
merge. This creates three laminae: one in the center and one on either side of the vein. As 
fluorescein filling increases in the veins, the laminae eventually enlarge and meet, resulting in 
complete fluorescence of the retinal veins. 
 Fluorescence of the disc emanates from the posterior ciliary vascular system, both from the 
edge of the disc and from the tissue between the center and circumference of the disc. Filling also 
comes from the capillaries of the central retinal artery on the surface of the disc. Because healthy 
disc tissue contains many capillaries, the disc becomes fairly hyperfluorescent on the angiogram. 
 The perifoveal capillary net cannot always be seen on the fluorescein angiogram. It can be 
seen best in young patients with clear ocular media, about 20 to 25 seconds after a rapid 
fluorescein injection. This is called the "peak" phase of the fluorescein angiogram. The 
photographer should be aware of this phase and be sure not to miss it by shooting as rapidly as 
possible as the fluorescein concentration increases, and by continuing to shoot rapidly until the 
concentration of fluorescein begins to decrease. 
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 Approximately 30 seconds after injection, the first high-concentration flush of fluorescein 
begins to empty from the choroidal and retinal circulations. Recirculation phases follow, during 
which fluorescein in a lower concentration continues to pass through the circulation of the fundus. 
 Later, generally 3 to 5 minutes after injection, the choroidal and retinal vasculatures slowly 
empty of fluorescein and become gray. Vessels of most normal patients almost completely empty of 
fluorescein in approximately 10 minutes. The large choroidal vessels and the retinal vessels do not 
leak fluorescein. However, because of large gaps in its endothelium, the choriocapillaris does leak 
fluorescein. The extravasated fluorescein diffuses through the choroidal tissue, Bruch's membrane, 
and sclera. Leakage of fluorescein with retention in tissues is designated as staining. In the later 
phase of the angiogram, staining of Bruch's membrane, choroid, and especially sclera may be 
visible if the pigment epithelium is lightly pigmented. The disc and adjacent visible sclera remain 
hyperfluorescent because of staining. When the retinal pigment epithelium is especially lightly 
pigmented, the large choroidal vessels can be seen in silhouette against the fluorescent 
(fluorescein-stained) sclera. The lamina cribrosa within the disc remains hyperfluorescent because 
of staining. This depends on the cup-to-disc ratio and the presence of any visible sclera, such as 
occurs within a conus adjacent to the disc. The edge of the disc stains from the adjacent 
choriocapillaris, which normally leaks. 
 To summarize, the angiogram is initially dark; choroidal and retinal filling is seen 10 to 15 
seconds after fluorescein injection. The retinal and choroidal vasculatures fill maximally about 20 to 
30 seconds after injection. Late angiophotographs show fluorescence of the choroid and sclera (if 
the pigment epithelium is light) and fluorescence of the optic cup and the edge of the disc, but 
otherwise the fundus is dark (nonfluorescent in the late phase). 
  Fluorescein angiography is the most important diagnostic tool for the retinal specialist. It also has 
proved to be useful in the treatment and management of patients who have particular retinal 
disorders. The major limitation of fluorescein angiography is the inability to visualize the choroidal 
circulation accurately. New diagnostic techniques, such as indocyanine green angiography, have 
become complementary to the evaluation of choroidal diseases. 
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2.2 INDOCYANINE GREEN ANGIOGRAPHY 
 
Definition 
  • An infrared-based imaging technique used to detect choroidal abnormalities. 
  • Greatest utility is for the detection of occult, poorly defined forms of choroidal  
     neovascularization. 
  • Increases the number of patients potentially treatable, using laser photocoagulation. 
 
Introduction 
      Indocyanine green (ICG) angiography is an infrared-based, dye-imaging technique that is most 
useful for the evaluation of patients who have exudative changes from choroidal neovascularization 
(CNV). Specifically, patients who have age-related macular degeneration and who are found to 
have occult (obscured by hemorrhage, exudate, or pigment) or poorly defined CNV via fluorescein 
angiography may be evaluated using ICG angiography to delineate any CNV that may be treatable 
with laser photocoagulation. Since 85% of patients who have CNV caused by age-related macular 
degeneration fall into these categories, ICG angiography enables additional patients to be treated. 
In addition, ICG angiography is used to detect occult recurrences of CNV following laser 
photocoagulation. 
     With respect to other choroidal disorders, which include tumors and inflammatory disorders, ICG 
angiography is of some diagnostic value. A more limited use for ICG angiography is in individuals 
who are allergic to fluorescein dye, which may be used to image retinal vascular disorders. When 
imaging is necessary for diagnostic or therapeutic indications, ICG angiography can serve as a 
substitute. 
 
Historical Review 
      Flower and Hochheimer first studied indocyanine green (ICG) angiography in depth, reported in 
1972 [17]. The utility of these early experiments was limited by the photographic media used to 
record the angiographic images. Since ICG has a fluorescent efficiency 25 times less than that of 
sodium fluorescein, the infrared film used for ICG angiography in these initial studies was 
insufficient to yield angiograms of acceptable quality. Orth et al. in 1976 used a movie camera to 
record the angiographic images [18], but even at speeds of 20 frames per second the filming 
technique was insufficient to study the choroidal circulation effectively. 
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 In addition, the apparatus did not enable the investigators to view the fundus while the 
angiography was performed. 
  During the 1980s, major technologic advances paved the way for clinically useful ICG 
angiography. First, the quality of excitatory and emission barriers was improved greatly. These 
filters, which selectively limit the passage of light to the appropriate infrared wavelengths, 
decreased the overlap transmission to 0.5%. The second major technologic advance was the 
introduction of videoangiography by Destro and Puliafito [19]. Videoangiography employs an 
infrared-sensitive video camera and videocassette recorder to record the fluorescent images 
obtained during angiographic procedures. The video camera proved to be much more sensitive than 
infrared film for the capture of ICG's fluorescence, and enabled satisfactory imaging of the choroidal 
circulation. The quality of angiograms stored on videocassette was limited to 320 lines of resolution. 
Modern ICG imaging systems utilize digital videoangiography, in which fluorescent images of ICG 
dye are recorded from the fundus via an infrared-sensitive analog video camera attached to a 
computer. Image resolution is improved vastly, because this system allows 1024 lines of resolution. 
 
Purpose of the Test 
     Abnormalities of the choroidal circulation are detected using indocyanine green (ICG) 
angiography, particularly choroidal neovascularization (CNV). Analogous to fluorescein angiography, 
the phases of the ICG angiogram can be divided into temporal categories. Although the clinical 
utility of division of the ICG angiogram into phases is limited, it is useful for the establishment of a 
normal baseline for comparison with pathologic conditions. The early phase is characterized as the 
first appearance of ICG dye in the choroidal circulation, which occurs within 1 minute after injection 
of ICG. Large choroidal arteries and veins are highlighted, as well as the retinal vasculature. 
Between 5 and 15 minutes after injection the middle phase is entered, in which the choroidal veins 
become less distinct and a diffuse, homogeneous choroidal fluorescence is observed. The 
hyperfluorescence of the retinal blood vessels diminishes. During this phase, hyperfluorescent 
lesions begin to appear in contrast against the fading background fluorescence. In the late phase, 
which occurs approximately 15 minutes after injection of ICG, no details of the retinal or choroidal 
vasculature are observable. The optic disc is dark and the large choroidal vessels become 
hypofluorescent. During this phase, choroidal abnormalities stand out in contrast to the markedly 
diminished background fluorescence. It is during the late phase that CNV is detected as a 
hyperfluorescent lesion. 
  Terms specifically related to ICG imaging of CNV include 'focal CNV' (sometimes referred to as a 
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'hot spot'), which often represents an area of occult CNV. Hot spots, by definition, are less than 1 
disc diameter in size and are well delineated (see Fig.5).Typically, these lesions are not obscured by 
hemorrhage or exudate. 'Placoid hyperfluorescence' is another term that relates to findings on ICG 
angiography, and describes an area of occult CNV that is larger than 1 disc area in size (see Fig.6) 
that may or may not be well defined in the early phase of the ICG angiogram. In the late phase of 
the ICG angiogram, the staining of CNV may be well defined and is not obscured by hemorrhage or 
exudate. If the borders are not distinct because of late leakage of ICG or the borders are obscured 
by hemorrhage or exudate, the lesion is not considered to be well defined by ICG angiography. For 
CNV that is well defined or classic in appearance on fluorescein angiography, the appearance on 
ICG angiography is variable [20]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.5  Serous retinal pigment epithelial detachment associated with a hot spot. (a) Late-phase 
fluorescein angiogram illustrates filling of a serous pigment epithelial detachment. No well-defined 
or classic choroidal neovascularization is observed. (b) Corresponding midphase ICG angiogram 
showing a hot spot at the margin of the pigment epithelial detachment. 
FA ICG 
FA ICG 
Fig.6  Retinal pigment epithelial detachment and placoid area of hyperfluorescence. (a) Late-phase 
fluorescein angiogram illustrates a large area of hyperfluorescence consistent with a retinal pigment 
epithelial detachment. (b) Corresponding midphase indocyanine green angiogram shows a placoid 
area of hyperfluorescence. 
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Utility of the Test 
      
The greatest utility for indocyanine green (ICG) angiography is in the identification and 
delineation of poorly defined choroidal neovascularization (CNV) and CNV associated with age-
related macular degeneration obscured by hemorrhage, exudate, or pigment (occult) [21]. 
  For the imaging of choroidal circulation, ICG angiography has several advantages over fluorescein 
angiography. After intravenous injection, ICG is bound readily and rapidly to serum proteins. In 
fact, 98% of ICG is transported in the blood bound to serum proteins, which compares to only 60-
80% of fluorescein that is protein bound. The advantage of being more protein bound is that the 
amount of leakage through the fenestrations of the choriocapillaris is reduced, which results in 
enhanced definition of larger choroidal vascular channels, the normal choroidal circulation, and 
CNV. Fluorescein angiography normally does not demonstrate the choroidal circulation well, 
because the unbound fluorescein molecule is very small and rapidly leaks from the choriocapillaris, 
obscuring the underlying choroidal vessels. Poorly defined or occult CNV appears to be stained by 
ICG during the late phase of the ICG angiogram. Late leakage from abnormal blood vessels 
probably causes fibrous tissue to be stained with ICG. In contrast, fluorescein, which easily diffuses 
from fibrovascular tissue, does not stain this tissue well, and so observation of this form of CNV is 
difficult. 
  Another advantage of ICG angiography is its fluorescence in the near-infrared spectrum. The 
retinal pigment epithelium and choroid absorbs approximately two thirds of light at 500nm, but only 
one third of light at 800nm (see figure 7). Therefore, light at wavelengths in the near infrared are 
able to penetrate the pigmented layers of the fundus much better than light in the visible spectrum 
utilized by fluorescein angiography. Similarly, near-infrared light is able to penetrate lipid deposits, 
serous exudation, and hemorrhage better than visible light [22,23]. 
 
 
 
 
 
 
 
 
 
Fig. 7. In this graphic the excitation and 
emission curves are displayed. The near 
infrared fluorescence of ICG permits 
better penetration through the fundus 
layers when compared with  FA. 
Compare with the excitation and 
emission curves of FA in figure 1. 
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  Also, ICG angiography is useful for the detection of occult forms of persistent or recurrent CNV 
[24,25]. Fluorescein angiography is considered the ancillary test of choice for the identification of 
recurrent CNV. In some cases, however, recurrent CNV may be suspected on clinical examination, 
yet clear evidence of new vessels may not be ascertained using fluorescein angiography. In such 
situations, ICG angiography has proved to be a useful adjunct as it may delineate hot spots 
consistent with recurrent, poorly defined CNV. When recurrent CNV is suspected but not observed 
on fluorescein angiography, well-defined (and potentially treatable) recurrent CNV can be detected 
in an additional 15% of cases, using ICG angiography. 
 Well-defined or classic CNV has a variable appearance on ICG angiography. When there late 
leakage is associated with a well-defined CNV on fluorescein angiography (type II occult CNV), ICG 
angiography may more completely delineate the extent of the lesion. Therefore, in eyes suspected 
to harbor classic and type II occult CNV, ICG angiography may delineate more completely both 
well-defined and ill-defined lesions and serve as a guide for treatment [26]. 
  Studies of ICG angiography in patients who are affected acutely with central serous 
chorioretinopathy reveal diffuse hyperfluorescence in the early stage of the angiogram, presumably 
caused by hyperpermeability of the choroid (Fig.8).  
 
 
 
 
 
 
 
 
 
 
 
 
Retinal pigment epithelial detachments are observed more readily on ICG angiography and are 
characterized as a ring of hyperfluorescence that surrounds a hypofluorescent spot. Areas of ICG 
hyperfluorescence can be seen in eyes that have inactive disease or in the inactive or 'normal' 
fellow eye [27]. Fluorescein angiography typically shows fewer abnormalities in unaffected eyes. 
FA ICG 
Fig.8  Idiopathic central serous choroidopathy. (a) Arteriovenous-phase fluorescein 
angiogram shows the multiple focal leakage points. (b) The corresponding late-phase 
indocyanine green angiogram demonstrates a large area of diffuse hyperfluorescence. 
 66
Therefore, results obtained from ICG angiography may play an important role in the diagnosis of 
central serous chorioretinopathy and describe accurately the possibility of recurrences and 
involvement of the fellow eye to the patient afflicted with this condition. 
  Although ICG angiography is of limited value in the diagnosis and evaluation of disorders of the 
retinal circulation, ICG angiography may demonstrate some features of retinal conditions that are 
observed during fluorescein angiography. Therefore, in individuals who are allergic to fluorescein, 
ICG may play a role in the evaluation of retinal vascular disorders. 
  For the assessment of choroidal tumors and inflammatory conditions, ICG angiography appears to 
be of limited value. Idiopathic polypoidal choroidal vasculopathy has a characteristic appearance on 
ICG angiography (Fig. 9), which is useful for the differentiation of this condition from occult CNV 
[28]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Procedure 
     The technical aspects of the capture of images described herein relate to the use of intravenous 
doses of 25mg of indocyanine green (ICG). Higher dosages typically result in larger degrees of 
hyperfluorescence, and thereby change excitation; gain also may vary. The ICG dye is dissolved in 
the manufacturer's diluent and administered intravenously as a bolus, after which a normal saline 
flush is given. If both fluorescein and ICG angiography are performed sequentially, an intravenous 
catheter may be placed to save the patient from multiple needle sticks. 
  Excitation illumination should be at a maximum with a video gain of +6db. Approximately 10 
images are acquired over the initial 30 seconds, starting immediately after injection. The video gain 
Fig.9  Idiopathic polypoidal vasculopathy. (a) Red-free image illustrates multiple, hemorrhagic 
pigment epithelial detachments. (b) Indocyanine green angiography reveals saccular dilatations of 
choroidal vessels consistent with idiopathic polypoidal vasculopathy. 
ICG 
a b 
RED FREE 
PHOTO 
 67
and excitation illumination levels should not be changed during the transit phase unless image 
bloom occurs (an increased fluorescence that obscures images). If this happens, the excitation level 
is reduced. The best images are retained and, ideally, the transit of ICG through the choroidal 
vasculature is captured again every 15 seconds. Late images at 5, 10, 15, and 20 minutes after 
injection also are obtained. Alteration of the excitation level can be increased during the late phase 
of the ICG angiogram if signal intensity is reduced. In the very late stages, both excitation and 
video gain can be increased; however, a concomitant reduction in detail results. 
 
Complications 
     Indocyanine green (ICG) has proved to be a safe and well-tolerated dye for diagnostic imaging. 
Minor adverse reactions are uncommon following ICG injection, but include discomfort, nausea, 
vomiting, and extravasation of dye. True, life-threatening anaphylactic reactions are very rare, but 
occur in equal incidence following ICG and fluorescein injection (1:1900). Current contraindications 
to ICG angiography include prior anaphylactic reaction to ICG dye or contrast agents that contain 
iodide, liver disease, uremia. Pregnancy should not be considered an absolute contraindication for 
ICG angiography. There is a documented safety of ICG when used intravenously to measure 
hepatic blood flow in pregnant women. Despite this in a survey among vitreoretinal-trained 
physicians regarding the use of indocyanine green (ICG) angiography during pregnancy, the current 
practice showed patterns unnecessarily restrictive [29]. 
    Approximately 5% of current commercial ICG dyes contain iodide, and, therefore, ICG is 
contraindicated in patients who have iodide allergies. 
 
Interpretation of Results 
      Digital images obtained during indocyanine green (ICG) angiography can be printed using 
either a digital, continuous tone printer, a laser printer, or a thermal printer. 
High-resolution, 35mm slides may be generated directly from the system monitor, as may digital 
image formats that can be processed. Software available with the ICG system enables the user to 
manipulate the angiographic images. For example, the 'trace' function allows areas to be copied 
from the ICG angiogram and placed at the precise location on a red-free photograph. This is helpful 
when ICG angiography is used as a guide for laser photocoagulation. 
     For the evaluation of occult or obscured forms of CNV, the images obtained are examined for 
abnormal areas of hyperfluorescence. Comparison of the ICG angiogram is made against the 
fluorescein angiogram and slit-lamp biomicroscopy images of the fundus in an attempt to correlate 
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the findings. Although no randomized studies have been carried out to prove the efficacy of ICG-
guided laser treatment, practitioners in general treat focal hot spots that are not subfoveal in 
location. Those hot spots that are associated with serous retinal pigment epithelial detachments 
have a less favorable prognosis and may not be treated [30-33]. Therefore, another 10-20% of 
patients who have exudative, age-related macular degeneration may be eligible for laser treatment 
if ICG angiography is used compared to those studied with fluorescein angiography alone. 
 
Alternative Tests 
      Indocyanine green (ICG) angiography also may be performed using the scanning laser 
ophthalmoscope, or by directly obtaining videoangiograms without digitization. These techniques 
allow for continuous images to be produced, which, therefore, allows flow through the choroidal 
circulation to be imaged. Results similar to those of digital videoangiography can be obtained using 
these systems. 
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3.1 INTRODUCTION 
 
Definition 
  • A chorioretinal disorder characterized by an idiopathic serous detachment of the  
     neural retina in the macular region. 
   
Key Features 
  • One or more focal areas of subretinal fluid in the macula. 
  • One or more focal leaks at the level of the retinal pigment epithelium. 
   
Associated Features 
  • Retinal pigment epithelial detachment. 
  • Mottling of the retinal pigment epithelium. 
  • Yellowish-white subretinal deposits. 
  • Unilateral or bilateral involvement. 
  • Recurrences. 
  • Dependent, bullous retinal detachment. 
  Central serous chorioretinopathy (CSC) is a common retinal disorder characterized by an idiopathic 
serous neural retinal detachment in the macular region [1,2] (Fig.1).  
 
 
 
 
Since its initial description as relapsing central 
syphilitic retinitis by von Graefe in 1866 [3], it 
has been referred to by many names, 
including central serous retinopathy, central serous pigment epitheliopathy, and central serous 
retinitis. The most common symptoms of CSC include metamorphopsia, blurred vision, and 
micropsia. Visual disturbances typically take several months to resolve [1,2]. The most surprising 
aspect of the disease is the relative preservation of retinal function despite prolonged separation 
from the retinal pigment epithelium. Occasionally, the macular detachment may fail to resolve 
Fig 1 Fundus photograph of central 
serous chorioretinopathy. Note the 
neural retinal detachment of 2 disk 
diameters in the macular region, the 
pigment epithelial abnormalities 
inferonasal to the fovea, and the 
numerous tiny yellow dots on the 
undersurface of the retina. 
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spontaneously; for these eyes, laser photocoagulation appears beneficial as it accelerates the 
resorption of subretinal fluid and improves vision [4-6]. 
     
 3.2 Epidemiology and Pathogenesis 
    Typically, CSC affects men in the age range 20-50 years. No case has been reported under the 
age of 20 years. In patients older than 50 years, CSC does occur but can be difficult to distinguish 
from age-related macular degeneration. An increased frequency may exist in intelligent individuals 
engaged in visually demanding work who display type A personality traits or who are experiencing 
physical strains or emotional stress. A history of migraine-type headaches may be elicited [1,2]. 
Also, CSC has been associated with vasoconstrictive agents [7], endogenous hypercortisolism [8], 
and systemic corticosteroid use [9]. It can be produced in animals by repeated intravenous 
epinephrine (adrenaline) injections [7]. 
  The understanding of the pathogenic accumulation of subneural retinal fluid in the macular region 
is limited. Few pathologic studies have been performed and the observations from angiographic, 
clinical, and experimental models are subject to interpretation. It is well known, however, that the 
subneural retinal fluid originates from the choroid. The leakage of dye through an abnormal focal 
defect at the level of the retinal pigment epithelium (RPE) and its accumulation in the subneural 
retinal space is seen clearly on fluorescein angiography [1,2] (Fig.2). 
 
 
 
 
 
 
 
 
 
 
  
The cause of the focal RPE leak is unclear. At first it was proposed that a simple break down of 
the blood-retinal barrier at the RPE level was responsible for the leak [10]. However, this theory 
does not explain the beneficial effect of the permanent RPE barrier breakdown produced during 
laser photocoagulation. Later, it was suggested that the subneural retinal fluid pooled 
Fig.2  Fluorescein angiogram of central serous chorioretinopathy. (a) Early phase reveals focal 
leakage nasal to the macula. (b) Late phase demonstrates pooling of the dye within the subneural 
retinal space. 
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Fig.3  Indocyanine green angiogram of 
central serous chorioretinopathy. Contrast 
enhancement revealed a focal area of 
hyperfluorescence during the midphase of 
the study. Fluorescein angiography 
demonstrated no leakage in the 
corresponding area. 
secondary to a collection of pathologically hypersecreting RPE cells [11], but this theory fails to 
explain the widespread choroidal hyperpermeability seen with indocyanine green angioraphy 
(Fig.3). 
  Increasing evidence implicates impaired 
choroidal circulation in the cause of CSC. 
Using indocyanine green angiography, 
Prunte and Flammer showed delayed 
choroidal capillary lobular filling in areas of hyperpermeability [7]. They proposed that localized 
capillary and venous congestion in the affected lobules impaired the circulation, produced ischemia, 
and allowed increased choroidal exudation and a focally hyperpermeable choroid [7]. This abnormal 
structure allows the accumulation of excess choroidal fluid and produces a retinal pigment epithelial 
detachment. As the detachment grows, the target junctions between RPE cells are broken and a 
focal defect of the blood-retinal barrier develops. Choroidal fluid passes through this opening and 
produces a neural retinal detachment [12]. 
 
3.3 Ocular Manifestations 
      Although unilateral metamorphopsia is the classic symptom of central serous chorioretinopathy 
(CSC), patients also may present with unilateral blurred vision, micropsia, impaired dark adaptation, 
color desaturation, delayed retinal recovery time to bright light, and a relative scotoma. Visual 
acuity ranges from 20/15 (6/5) to 20/200 (6/60), but averages 20/30 (6/9). The visual acuity may 
improve with hyperopic correction. Symptoms typically resolve after several months, but may linger 
even after the fluid resolves; only rarely do they persist indefinitely. Permanent sequelae include 
metamorphopsia, decreased brightness perception, and altered color vision [1,2]. 
  Also, CSC can present as a bullous, inferior nonrhegmatogenous peripheral retinal detachment. 
The presence of retinal pigment epithelium atrophic tracts from the macular region to the 
peripheral detachment, seen best with fluorescein angiography, reveal the true diagnosis and 
source of the subretinal fluid [13]. 
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  A chronic form of CSC exists as well. In about 5% of cases, a diffuse retinal pigment 
epitheliopathy progresses in conjunction with persistent or intermittent subretinal fluid. The retinal 
detachments tend to be shallower and more diffuse than in the classic form. The visual prognosis is 
more guarded. 
 
    3.4 Diagnosis 
    The diagnosis of central serous chorioretinopathy (CSC) is clinical and confirmed with fluorescein 
angiography. While in most cases the diagnosis can confidently be made without ancillary testing, 
the information derived from angiography is critical to detect the extent of the retinal abnormalities 
and to exclude the presence of other pathology. 
  Biomicroscopically, a transparent blister in the posterior pole between the neural retina and the 
retinal pigment epithelium (RPE) is observed. This is best seen through a fundus contact lens with a 
wide light beam, set slightly off axis. Signs that suggest the presence of a retina-RPE separation 
include beam splitting as the light traverses the serous space, an increased distance between the 
retinal vessels and their shadows, and an absent foveal reflex. Shallow detachments may be 
difficult to demonstrate clinically [2]. 
  The subretinal serous fluid within the blister often is transparent. This fluid may have protein and 
fibrin and be turbid or yellowish, especially in more pigmented individuals or in pregnant women. It 
is believed that the small dot-like deposits that form on the posterior surface of the retina or on the 
anterior surface of the RPE cells under the area of the detachment represent precipitates of this 
protein [2]. This is noted best when the fluid component is resolving. Diffuse deposits of serous 
proteins can produce a whitish retinal appearance that mimics intraretinal edema. A normal retinal 
thickness and transparency help to distinguish this from true retinal edema [2]. 
 Oval yellow-gray elevations beneath the detachment also may be seen. These are generally 
less than one-fourth of a disk diameter in size and are surrounded by a faint grayish halo. 
Fluorescein angiography identifies them as retinal pigment epithelial detachments (RPEDs) and 
frequently demonstrates the focal RPE leaks responsible for the neural retinal detachment within 
their borders. Since subretinal exudative fluid may track inferiorly in response to gravity, a leaking 
RPED may lie beyond the superior margin of its retinal detachment. Numerous factors can help 
differentiate an elevated RPED from a shallow focal retinal detachment [2]: 
  • an RPED obscures the choroidal pattern (this characteristic may abate as the RPE cells in the 
RPED atrophy); 
  • the boundary of the RPED typically is better defined than the edge of the retinal detachment; 
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and 
  • an RPED bows the light beam reflex forward toward the observer and prevents visualization of 
the sub-RPE space. 
  A large RPED must be differentiated from an amelanotic melanoma or metastatic lesion to the 
choroid. Both can appear dome-shaped, solid, nontranslucent, and produce an overlying 
neurosensory detachment [2]. 
  The presence of cystic retinal degeneration, fine RPE mottling, or RPE clumping suggests 
chronicity of the present episode or a history of a previous CSC episode (Fig.4).  
 
 
 
 
Additional ophthalmoscopic findings, 
such as lipid or hemorrhage, are rare and 
should call into question the diagnosis of 
idiopathic CSC [2]. The fellow eye may show 
evidence of either concurrent or previously 
resolved CSC, manifested as focal areas of 
RPE rarefaction or small asymptomatic 
RPEDs. 
  Fluorescein angiography plays an important role in the evaluation of CSC. It is used to exclude the 
presence of other pathologies that produce neural retinal detachments and yet also confirms the 
diagnosis. Classically, dye from the choroid leaks through a focal RPE defect and pools in the 
subretinal space. In over 75% of patients, this pooling occurs within 1 disk diameter of the fovea 
[14]. Less pooling may be observed in older lesions in which the RPE exudate has become 
inspissated [2]. When fluorescein angiography is atypical, indocyanine green angiography can help 
to exclude the presence of other pathology. Indocyanine green angiography of CSC reveals 
multifocal choroidal hyperfluorescence in affected and unaffected regions of both the active and 
fellow eyes [15,16]. 
  A new, noninvasive technique of ocular imaging called optical coherence tomography can 
demonstrate the presence of subretinal fluid. In cases of CSC, optical coherence tomography has 
been used successfully to quantify the amount and extent of subretinal fluid [17]. 
 
Fig.4  Fundus photograph of an eye 
with resolved central serous 
chorioretinopathy showing chronic 
pigmentary changes.  
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    3.5 Differential Diagnosis 
    Serous elevations of the neurosensory retina in the macular region can be produced by diseases 
of the choroid, retinal pigment epithelium (RPE), and retina. Chorioretinal neovascular membranes, 
optic disk pits, choroidal melanomas, choroidal metastasis, choroidal hemangiomas, uveitis, 
Harada's disease, optic neuritis, papilledema, vitreous traction, peripheral rhegmatogenous retinal 
breaks, macular holes, and systemic hypertension can all produce neural retinal detachments [2]. 
  In particular, central serous chorioretinopathy (CSC) must be differentiated from a neural retinal 
detachment secondary to optic disk pits or subretinal choroidal neovascularization. Differentiation 
from a neural retinal detachment secondary to choroidal neovascularization may prove particularly 
difficult since both share many of the same signs, including neural retinal detachment, retinal 
pigment epithelial detachment (RPED), RPE changes, and subretinal exudate. Since their prognosis 
and treatment drastically differ, fluorescein angiography should be considered in all cases of 
presumed CSC. 
  When fluorescein angiography is unable to exclude the presence of choroidal neovascularization, 
indocyanine green angiography can be considered. Indocyanine green angiography of CSC 
demonstrates specific patterns of hyperfluorescence that differ distinctly from those of neovascular 
membranes. The hyperfluorescence of CSC commonly is bilateral, present in affected and 
unaffected areas of the choroid, occurs during the midphase of the angiogram, and is later 
silhouetted against the larger choroidal vessels as the dye diffuses throughout the choroid. In 
contrast, choroidal neovascularization produces a unifocal hyperfluorescence that progressively 
increases during the later phases of the angiogram. Occult RPEDs appear on indocyanine green 
angiography as areas of early hyperfluorescence, with central hypofluorescence appearing later 
[17]. If the presence of a choroidal neovascular membrane still remains a possibility, it may be 
prudent to observe the patient and repeat the angiography after 2 weeks, since a choroidal 
neovascular membrane is likely to grow with time; however, a CSC area of focal leakage is likely to 
stay constant or regress with time. 
 
3.6 Systemic Associations 
      Usually, central serous chorioretinopathy (CSC) is an isolated idiopathic ocular disorder. 
Patients, however, may show the presence of various CSC risk factors, including type A personality 
traits or a recent episode of stress [1,2]. 
  Also, CSC has been associated with hypercortisolism [8] and systemic corticosteroid use [9]. The 
observation of increased CSC symptoms during periods of increased corticosteroid use and their 
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subsequent resolution when dosages are decreased led to this discovery. Bouzas et al. reported a 
CSC prevalence of 5% among patients with endogenous Cushing's syndrome [8]. Corticosteroids 
are believed to induce serous retinal detachments through damage to the retinal pigment epithelial 
barrier [9]. 
  Multiple diseases that share the underlying choroidal vascular dysfunction have been linked to 
classic CSC or to a visual syndrome that mirrors the disease. These include accelerated 
hypertension, pregnancy, dialysis, organ transplantation, and systemic lupus erythematosus [18-
22]. 
 
3.7 Pathology 
     The benign course of central serous chorioretinopathy and the low incidence among the elderly 
have limited the number of pathologic studies. In those few performed, the retinal pigment 
epithelium (RPE), choroid, and retinal vessels appear normal. The only histopathologic changes 
observed include serous RPE detachments, serous detachments of the cuticular portion of Bruch's 
membrane, and cystic degeneration in the outer layers of the detached neural retina [2]. 
 
3.8 Treatment 
      The treatment of central serous chorioretinopathy (CSC) is laser photocoagulation to the site of 
fluorescein leakage. Although this has been proved to reduce effectively the duration of the serous 
detachment, it has no effect on the final visual prognosis and consequently is reserved for select 
patients [4-6]. It is the only therapy proved beneficial by large clinical trials. 
  The technique of laser photocoagulation involves using a green wavelength laser to produce a 
light scar over the focal retinal pigment epithelium (RPE) leak. Typically, 6-12 laser burns of 50-
200µm spot size at 0.1s duration and between 75-200mW are used [5]. Permanent RPE change is 
induced at the site of the laser scar. It has been suggested that while the scar facilitates the 
absorption of subretinal fluid via the choroid, it also destroys an area of abnormally hypersecreting 
RPE cells. The absence of any beneficial effect when the laser scar does not overlie the focal 
choroidal leak suggests the presence of a focal RPE abnormality [6]. 
  The only definite benefit from laser therapy is its ability to decrease the duration of the 
neurosensory detachment. This has been documented in numerous studies [4-6]. In 1974, Watzke 
et al. demonstrated that the median duration of disease decreased from 23 weeks in untreated 
eyes to 5 weeks in treated eyes [4]. Whether laser therapy is of benefit in decreasing the risk of 
recurrence remains an unresolved question. The 0% rate of recurrence observed by Yap and 
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Robertson [23] disagrees with the 34% recurrence recorded by Watzke et al. [4]. Both figures 
compare favorably with the 45% recurrence rate found by Klein et al. for untreated eyes [14]. 
  Complications from laser photocoagulation include choroidal neovascularization and central 
scotoma. Although rare, they can be visually devastating (see Fig.5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Larger spot sizes, lower intensities, and avoidance of the capillary-free zone reduce the 
incidence of these complications [6]. The rapid development of a choroidal neovascular membrane 
following laser photocoagulation suggests the possibility of an initial misdiagnosis [24]. 
  Since most CSC episodes resolve spontaneously, laser treatment is reserved for patients who fail 
to improve after 4-6 months, demonstrate permanent changes from CSC in their other eye, 
demonstrate multiple recurrences, or require improved vision for work. Treatment should be 
avoided if the leak occurs within 200µm of the center of the foveal avascular zone [6]. The 
application of photodynamic therapy (PDT) in these cases may be beneficial [25-27].  
  Despite isolated reports, no medical therapy is of proved value. Ongoing studies are currently 
investigating the beneficial role of systemic beta-blockers [28]. 
 
 
 
a b
c 
Fig.5  Choroidal neovascular 
membrane after laser photocoagulation 
for central serous chorioretinopathy.  
(a) Fundus of an eye with a 2-year 
history of recurrent CSC. Note the 
neurosensory detachment and the 
numerous fine yellow deposits 
under the retina. 
(b) Fundus showing subretinal blood at 
the treatment site.  
(c) Late-frame fluorescein angiogram  
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3.9 Course and Outcome 
      Generally, the visual prognosis is good. The majority of patients suffer no significant permanent 
visual loss. In a series of 34 eyes with central serous chorioretinopathy (CSC) followed for an 
average of 23 months without treatment [14], visual acuity was no worse than 20/40 in any eye. 
This was despite large neural retinal detachments, multiple retinal pigment epithelium (RPE) leaks, 
cystoid macular changes, persistent retinal pigment epithelial detachments, and marked visual loss 
during acute episodes. The persistent Amsler chart changes present in 24 of 27 eyes were 
described as visually insignificant and causing no difficulty. Although visual acuity usually improves, 
patients may continue to have persistent metamorphopsia. 
In a recent retrospective study of cases of unilateral resolved CSC imaged with high-resolution 
optical coherence tomography (OCT), there are a number of morphologic changes in the fovea that 
are associated with relatively good visual acuity [29]. 
  Rarely, CSC can produce significant visual damage, usually caused by the chronic form of the 
disease. Retinal pigment epithelial atrophy, a metallic sheen at the level of the RPE, drusen, and 
choroidal neovascularization also have been described in eyes with untreated CSC [17]. Cases 
called 'CSC' exist in which bullous neurosensory detachments extend from the posterior pole to the 
most dependent part of the retina. 
  Follow-up fluorescein angiography of eyes with CSC suggests that, in certain patients, CSC may be 
the herald for a bilateral progressive RPE disturbance known as chronic central serous 
chorioretinopathy [30]. It remains unresolved whether a history of CSC exacerbates the natural 
course of age-related macular degeneration. 
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CHAPTER 4. 
 
AIM OF THE STUDY 
 
The aim of our study is mainly to analyze the findings from ICG angiograms and to correlate 
them with the clinical and FA results in the affected and non-affected eyes and secondarily to 
provide some clues to the pathophysiologic and pathogenetic mechanisms of the disease. 
 
Using the conventional technique of FA and clinical examination we are not able to investigate 
the role of choroid in the course of this disease. Using ICG angiography in our study we will try to 
find the alterations of the choroid. 
 
The disease is probably active in the majority of the cases although it is considered inactive 
when we use the conventional criteria of FA and clinical examination. The verification of this 
hypothesis may alter the already classification of the disease. 
 
A secondary outcome of this study are the results of the long-term follow-up of these patients. 
This provide us some clues with regard the visual acuity of the patients in the different forms of the 
disease, the number of relapses, the evolution of the retinal alterations and  the concomitant 
administration of steroids or the coexistence of a non-ocular systemic disease. 
 
The primary and secondary outocomes of this study not only contribute to the better 
understanding of the etiology and the pathogenesis of CSC but also additionally provide a more 
complete picture of this peculiar disease that is considered until nowdays a disease of unknown 
etiology.  
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CHAPTER 5. 
 
PATIENTS AND METHODS 
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Our study included 20 consecutive patients (22 eyes), that were affected by central serous 
chorioretinopathy (CSC). We excluded from our study all patients with a history of ocular trauma, 
vascular inflammatory and tumoral fundus manifestations resembling CSC clinical and FA features, 
eyes with macular drusens and patients with signs of choroidal neovascularization or any other 
ocular disease. Special attention was also given to the medical history of the patient with regard to 
the administration of any form of steroids (systemic or topical). Sixteen patients were male and 
four were female (male/female=16/4). The average age (mean ±S.D) of the patients was 45.6 ± 
5.2 years old, and the range was between 35 and 56 years. Only one patient was black while the 
rest – 19 patients were white. Regarding their nationality one patient (5%) was from Central 
Africa, eight patients (40%) from countrties of Central Europe, and eleven patients (55%) from 
countries near and around the Mediterranean sea (30% Italian, 15% Spanish, and 10% French). 
Patients’ follow-ups varied between 13 months minimum and 90 months maximum with a mean 
period of observation (mean ±S.D) 33,1 ± 12,9 months. It is very important to point out that in 
35% of the patients (7 patients) there was an associated disease while in 15% (3 patients) there 
were two diseases. The main associated disease was chronic asthma (Chronic Obstructive 
Pulmonary Disease, COPD) appearing in six patients (30%). In three patients (15%) chronic 
asthma was associated with a second disease such as phototoxic dermatitis, ulcerative colitis and 
brain tumor. All these patients received steroids for the treatment of their primary disorder via 
different routes of administration (p.o, i.m, i.v, diadermatically, as inhalants or via the intranasal 
route). The patients of our study (20 patients) affected by CSC were divided in three separate 
groups according to the basis of their clinical history, fundus examination and fluorescein 
angiography findings as follows : acute CSC, 15 patients (15/20, 68,18%, 15 eyes), chronic CSC, 3 
patients (3/20, 22,7%, 5 eyes, in two of the patients the disease was bilateral), and healed-
inactive CSC, 2 patients (2/20, 9,1%, 2 eyes). Bilateral active CSC, was recorded only in two 
patients (10%) with chronic CSC. One of them had chronic asthma and and psoriasis and received 
steroids for treatment. Eight right eyes and fourteen left eyes were affected.  
Reccurence during the observation period was recorded in five patients (25%) of the group with 
active CSC. All of them received steroids and had an associated systemic disease. Demographical 
and the most important clinical data of our patients are displayed in tables 1 - 6. 
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Table 1.  
 
In this table the demographical and clinical data of our patients at baseline are displayed. 
 
Case 
No. 
Sex Age Race Eyes affected at  
first visit 
Best-Corrected VA at first visit 
(Decimal / logMAR units) 
Best-Corrected VA at final visit 
(Decimal / logMAR units) 
Follow-up 
ms 
Corticosteroids 
administration 
# 
Associated 
systemic 
disorders 
Nationality Type of 
CSC 
1 M 
 
56 white od-           os*  od: 1.0/0.0          os: 0.8/0.097  od: 1.0/0.0         os: 1.0/0.0 30 (-) (-) Central 
Europe 
active 
2 m 41 white od*           os-  od: 0.8/0.097      os: 1.0/0.0  od: 1.0/0.0         os: 1.0/0.0 22 (-) (-) Spanich active 
3 f 54 white od-           os*  od: 1.0/0.0          os: 0.3/0.523  od: 1.0/0.0         os: 0.8/0.097 42 (-) (-) Italian chronic 
4 m 50 white od*           os-  od: 0.6/0.2          os: 1.0/0.0  od: 0.5/0.301     os: 1.0/0.0 34 (-) (-) Italian active 
5 m 36 white od-           os*  od: 1.0/0.0          os: 0.8/0.097  od: 1.0/0.0         os: 1.0/0.0 30 (-) (-) Italian active 
6 m 41 white od-           os*  od: 1.0/0.0          os: 0.9/0.04  od: 1.0/0.0         os: 1.0/0.0 33 (+) Chronic 
asthma 
Italian active 
7 f 46 white od*           os-  od: 0.5/0.301      os: 1.0/0.0  od: 0.8/0.097     os: 1.0/0.0 27 (-) (-) Central 
Europe 
active 
8 m 51 white od-           os*  od: 1.0/0.0          os: 0.4/0.4  od: 1.0/0.0         os: 0.3/0.523 14 (+) Chronic 
asthma 
Central 
Europe 
active 
9 m 44 white od-           os*  od: 0.4/0.4          os: 0.9/0.04  od: 0.4/0.4         os: 1.0/0.0 48 (-) (-) Central 
Europe 
active 
10 f 49 white od-           os*  od: 1.0/0.0          os: 0.6/0.22  od: 1.0/0.4         os: 0.8/0.097 20 (+) Chronic 
asthma, brain 
tumor 
Central 
Europe 
active 
11 m 35 white od-           os*  od: 1.0/0.0          os: 0.7/0.155  od: 1.0/0.0         os: 0.7/0.155 61 (-) (-) Italian active 
12 m 52 white od*          os*  od: 1.0/0.0          os: 0.6/0.22  od: 1.0/0.0         os: 0.9/0.04 42 (+) Chronic 
asthma, 
phototoxic 
dermatitis 
French chronic 
13 m 43 white od-           os*  od: 1.0/0.0          os: 0.9/0.04  od: 1.0/0.0         os: 1.0/0.0 38 (+) Ulcerative 
colitis 
Central 
Europe 
inactive 
14 m 54 black od*           os*  od: 1.0/0.0          os: 0.6/0.22  od: 0.2/0.7         os:0.02/1.7 90 (-) (-) African chronic 
15 m 38 white od-           os*  od: 1.0/0.0          os: 0.8/0.097  od: 1.0/0.0         os: 1.0/0.0 38 (+) Chronic 
asthma, 
psoriasis 
Central 
Europe 
active 
16 m 46 white od*           os-  od: 0.9/0.04        os: 1.0/0.0  od: 1.0/0.0         os: 1.0/0.0 13 (-) (-) Central 
Europe 
active 
17 m 38 white od-           os*  od: 1.0/0.0          os: 0.8/0.097  od: 1.0/0.0         os: 1.0/0.0 13 (-) (-) French active 
18 m 49 white od*          os-  od: 0.6/0.22        os: 1.0/0.0  od: 0.6/0.22       os: 1.0/0.0 18 (-) (-) Spanich inactive 
19 f 47 white od*           os- od: 0.8/0.097       os: 1.0/0.0  od: 1.0/0.0         os: 1.0/0.0 26 (+) Chronic 
asthma 
Spanich active 
20 m 42 white od-           os*  od: 1.0/0.0         os: 0.8/0.097  od: 1.0/0.0         os: 1.0/0.0 22 (-) (-) Italian active 
Explanation of symbols and abreviations used in Table 1. 
-, non affected eye  
*, affected eye   
VA= visual acuity , od= right eye, os=left eye 
ms= months , m=male, f=female 
#= im, iv, pos, diedermical, as inhalants, or via intranasal route 
 
Table 2. 
Patients’ classification according to the current status in literatrure using clinical and fluroscein 
angiography data at baseline. The recurrence rate can also be seen. Recurrence was observed only 
in the active CSC group. 
 
Type of CSC Number of eyes / percentage % 
Reccurence during observation 
time 
ACTIVE CSC  
- total number of eyes 15 eyes / 68.18% 
- 1st affection  14 eyes / 63.63 % 
- as a recurrence from   
  previous insult 1 eye / 4.55 % 
5 eyes / 22.72 % 
INACTIVE CSC 2 eyes / 9.1% (-) 
CHRONIC CSC 5 eyes / 22.72% (-) 
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Table 3. 
Mean age of the chronic CSC group is greater than the two other groups. 
mean age ± S.D
Active CSC 44.0 ± 4.9 
Inactive CSC 46.3 ± 3.0 
Chronic CSC 53.4 ± 0.8 
Table 4. 
Comparison between BCVA a and BCVA af did not disclose any statistical significant difference 
(t=0,38 – p>0,05). The same was evident for the fellow eyes (BCVA b vs BCVA bf, t=0,5 – 
p>0,05). The only difference that appeared and remained during the observation period was 
between affected and fellow eyes at the first visit-baseline and at the end of follow-up (BCVA a vs 
BCVA b, t=0,005 – p<0,001 and BCVA af vs BCVA bf, t=0,035 – p<0,05) 
 
VISUAL ACUITY (mean value-decimal scale) 
 
affected eye fellow eye 
First visit (20patients – 22 eyes) BCVA a : 0.70 BCVA b : 0.96 
Final visit (20patients – 22 eyes) BCVA af : 0.66 BCVA bf : 0.96 
Abreviations used in table 4: 
BCVA a= Best corrected visual acuity in affected eyes at the first visit (baseline). 
BCVA af= Best corrected visual acuity in affected eyes at the end of the follow-up. 
BCVA b= Best corrected visual acuity in fellow eyes at the first visit (baseline). 
BCVA bf= Best corrected visual acuity in fellow eyes at the end of the follow-up 
Table 5. 
Statistical evaluation among the different groups with regard to the BCVA in affecterd eyes did not 
show any significant difference (p>0,05). 
 
VISUAL ACUITY  - FIRST VISIT 
(mean value-decimal scale) FORM OF THE CSC 
affected eye fellow eye 
Active CSC      (15 patients – 15 eyes) 0.72 0.94 
Inactive CSC     (2 patients – 2 eyes) 0.74 1.0 
Chronic CSC     ( 3patients – 5 eyes) 0.64 1.0 
Total                (20 patients – 22 eyes) 0.71 0.97 
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Table 6. 
On the contrary a significant difference appeared in the comparison of BCVA between active and 
chronic CSC groups (t=0,017 – p<0,05). 
 
VISUAL ACUITY  - FINAL VISIT 
(mean value-decimal scale) FORM OF THE CSC 
affected eye fellow eye 
Active CSC     (15 patients – 15 eyes) 0.83 0.94 
Inactive CSC    (2 patients – 2 eyes) 0.78 1.0 
Chronic CSC    ( 3patients – 5 eyes) 0.32 1.0 
Total               (20 patients – 22 eyes) 0.58 0.97 
 
For averaging visual acuities were converted to LogMAR units (decimal logarithm of the Minimum 
Angle Resolution), and then the mean calculated LogMAR acuities were reconverted to the decimal 
scale. Best corrected visual acuity (mean value in decimal scale) of the eyes with CSC in the first 
visit was 0.7, whereas in the final visit it was 0,66. The corresponding value of BCVA for the fellow 
eyes were 0.96 for both initial and final visit (see Table 4).  
Acute CSC was defined as the clinical form of the disease with localized neurosensory 
detachments with one or more focal fluorescein angiographic leaking points at the level of the 
retinal pigment epithelium (RPE) with or without a pigment epithelial detachment (PED) [27]. On 
the other hand chronic CSC was defined when there was widespread RPE alterations (atrophic RPE 
changes with or without chronic RPE decompensation) that could be ascribed to persistent or 
recurrent exudative manifestations [14,15]. The patients classified as having healed or inactive CSC 
when they had an acute CSC episode verified with clinical and FA examination that resolved 
spontaneously or after laser treatment (no neurosensory detachment and no focal point of 
fluorescein leakage). Choroidal perfusion defects in ICG angiograms were considered when we 
observed hypofluorescent choroidal areas that persisted when the surrounding choroidal veins were 
completely filled. The location and the actual number of leaking points were examined and 
compared with both FA and ICG angiography. The ICG hyperfluorescence (transient ICG leakage) 
was defined as the appearance of hyperfluorescence  
in the venous phase that subsequently spreads laterally and fades in a centrifugal movement 
(wash-out phenomenon).  
Each patient underwent a thorough ophthalmologic examination including fundus biomicroscopy, 
color fundus photography, and digital fluorescein FA and ICG angiography. Digital FA and ICG 
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angiograms were performed using the Topcon fundus camera TRC-W. The images obtained by the 
fundus camera were recorded by a high resolution camera (Videk Mega-plus Kodak, model 1.4; 
Eastman-Kodak, Rochester, NY) that was mounted with an interfacing adapter. This camera can 
convey high-resolution digital images (1024 X 1024) to a computer processing unit especially 
designed by Ophthalmic Imaging Systems (Sacramento, CA). All the images were displayed on a 
high resolution (1280 X 1024) monitor and stored on an optical laser disc for instant recall. We 
were also able to obtain a high-resolution hardcopy from the computer by using a digital continuous 
tone printer. Additionally FA and ICG was accomplished in some patients using Heidelberg fundus 
camera. 
Fluorescein angiography was performed by injecting sodium 5 ml fluorescein 10% into a 
peripheral arm vein, and ICG angiography was done in the same way by injecting 25 mg of ICG 
diluted in 3 ml of aqueous solvent. All the infusions of the dyes were followed immediately by a 5 
ml flush of sterile saline. Fluorescein angiography included a standard sequence of photographs 
while ICG images were obtained at 1-or 2-second intervals until the choroid was completely filled, 
and thereafter images were obtained at intervals of increasing length, over 30 to 45 minutes. 
Using the findings from ICG angiograms we analyzed the choroidal filling, vascular permeability 
and RPE alterations in correlation with the clinical and FA findings. 
Statistical evaluation was accomplished using pair and unpaired t-test. Statistical significance was 
considered for t-values greater than 0.05. 
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Baseline characteristics. 
 In our study we included 20 patients (22 eyes) with different clinical forms of the disease: 15 
patients with the active form (15 eyes, all of them were unilateral cases), two patients with inactive 
CSC (2 eyes), and 3 patients (5 eyes, in this group we had two patients with bilateral CSC) with the 
chronic form of the disease (see Table 2).  
Sex: Sixteen patients were male and four were female (male/female=16/4, male 
preponderance). 
Age: The mean age of the patients was 45.6 ± 5.24 years with a range between 35 and 56 
years. In the active CSC group this was 44.0 ± 4.9 years (range 35-55), s in the inactive CSC group 
(range 43-49) it was 46.0 ± 3.0 year, and it was 53.4 ± 0.8 years (range 52-54) in the chronic CSC 
form. With regard to the age of the patients, a statistically significant difference was evident among 
the chronic CSC group and the active (t=0.009 – p<0.01) and inactive groups (t=0.027 – p<0.05). 
The mean age of the patients belonging to the chronic CSC group is greater than that of the other 
two groups, whilst there is no difference between the mean age of the active and the inactive CSC 
groups. These results are displayed in table 3. 
Gender: Only one patient was black while the rest (19 patients) were white. Regarding their 
nationality one patient (5%) was from Central Africa, eight patients (40%) from countrties of 
Central Europe, and eleven patients (55%) from countries near and around the Mediterranean sea 
(30% Italian, 15% Spanish, and 10% French).  
Observation period: Patients’ follow-ups varied between 13 months minimum and 90 months 
maximum with a mean period of observation (mean ±S.D) 33,1 ± 12,9 months.  
Associated diseases: It is very important to point out that in 7 of our patients (35%) there 
was an associated disease while in three of them (15%) there were two diseases. The main 
associated disease was chronic asthma (Chronic Obstructive Pulmonary Disease, COPD) appearing 
in six patients (30%). In three (15%) of these patients chronic asthma was associated with a 
second disease such as phototoxic dermatitis, ulcerative colitis and brain tumor. All these patients 
(7 patients – 35%) received steroids for the treatment of their primary disorder via different routes 
of administration (p.o, i.m, i.v, diadermatically, as inhalants or via the intranasal route). Five 
patients with active CSC, one with inactive CSC and one with chronic CSC received steroids.  
Patients’ classification: Patients of our study (20 patients) affected by CSC were divided in 
three separate groups according to the basis of their clinical history, fundus examination and 
fluorescein angiography. The findings are as follows : acute CSC, 15 patients (15/20, 68,18%, 15 
eyes), chronic CSC, 3 patients (3/20, 22,7%, 5 eyes, in two patients the disease was bilateral), and 
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Figure 1. 
This patient had an active form of CSC and 
the classic ‘smoke-stack’ appearance in the 
FA. The ‘comet’ like alterations of the 
retinal pigment epithelium can also be 
observed inferior to the macula. The black 
arrow points to the fluorescein leakage 
while the white arrow to the alterations of 
the retinal pigment epithelium.
healed-inactive CSC, 2 patients (2/20, 9,1%, 2 eyes). Bilateral active CSC, was recorded only in two 
patients (10%) with chronic CSC. One of them had chronic asthma and psoriasis and received 
steroids for treatment. Eight right eyes and fourteen left eyes were affected. Reccurence during the 
observation period was recorded only in five patients (25%) of the group with active CSC. All of 
them received steroids and had an associated systemic disease. 
Visual acuity: Best corrected visual acuity (BCVA, mean value in decimal scale) of the eyes with 
CSC in the first visit was 0.70, whereas in the final visit it was 0,66 ± 0,23. The corresponding 
values of BCVA for the fellow eyes were 0.96 and 0.96. Significant differences in the mean BCVA 
were recorded only between the affected and fellow eyes in the first and final visit. The mean BCVA 
did not change during the observation period in the eyes with CSC nor in the fellow eyes (see Table 
4). A more detailed analysis and comparison of the mean BCVA of the affected eyes among the 
three different groups revealed a statistical significant difference between the active CSC group and 
the chronic CSC group only in the final visit (t=0,017 – p<0,05, table 5 and 6).  
Active CSC findings – Changes from baseline to endpoint of follow-up 
Baseline findings: Point or points of diffusion (POD or PODs) and serous retinal detachment were 
recorded in all the eyes of this group (15 eyes/100%). Bilateral PODs were not recorded while 
multiple PODs were evident in one eye (6,6%). In four out of the 15 affected eyes (26.7%) with 
the active form of CSC a classic focal leak with a ‘smoke-stack’ appearance was seen in FA (fig. 1).  
Retinal pigment epithelium 
detachment (PED) was disclosed in 6 
eyes (40%) (figure 2). Bilateral PEDs 
appeared in two eyes (13,4%, figure 
3) while there was a POD on PED 
only in two eyes (13,4%) (figure 4). 
Multiple PEDs were observed in 2 
eyes (13,4%) (figure 5).  
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Figure 4. 
A peculiar picture in FA was observed in the patients with the active form of CSC: this was the POD on PED. In this picture the two 
cases of our study were we recorded this phenomenon are shown. Early FA time of  the first case is shown inside the first picture 
The white arrows show the PEDs and the black arrow the POD. 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
 
 
Retinal pigment epithelium alterations were recorded in ten affected eyes (66,8%) and in 12 fellow 
eyes (80%). Although the leaking point was detected in all eyes (100%) with active CSC using FA. 
ICG angiography was able to detect the corresponding point (ICG point of diffusion – Subretinal 
leakage, SBRL) only in seven out of 15 eyes (46.6%). No additional point of leakage  
Figure 2. 
In this picture we can observe two PEDs located in the 
juxtafoveal area. POD that is located inside the PED 
can also be observed.The white arrows show the PEDs 
and the black arrow the POD. 
Figure 3. 
Bilateral PEDs were recorded in 13,4% in patients with 
active CSC. Here we present the FA of a patient with 
bilateral PEDs. White arrows point to the PEDs. 
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was detected in ICG angiography. The hyperfluorescence around the leakage point in ICG was 
diminished in size but still existed when compared with the first angiogram.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The classic ‘smoke-stack’ configuration of SBRL was recorded only in three eyes (20%, fig.6) in ICG 
angiography.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 
In the active form of the disease multiple PEDs were recorded in 13,4%. Multiple and bilateral PEDs are shown in this picture 
FA ICG
Figure 6. 
The classic ‘smoke-stack’ configuration of SBRL was recorded only in three eyes (20%). in this composite picture a comparison of the 
configuration of the dye leakage between the two dyes is shown. 
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ICG angiography in PEDs produced an even fluorescence in the early phases followed by a 
gradual fainting in the central portion, leaving a hyperfluorescent border at the end of the 
examination (figure 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In ICG angiogram we observed the same behaviour of the dye at the site of leakage. In the late 
phases of ICG angiograms we could observe a hyperfluorescent spot at the level of the RPE 
together with a diffuse staining of the subretinal fluid (figure 8). Surrounding the leakage point in 
100% of the affected eyes with active form of CSC there was an area of choroidal 
hyperfluorescence (choroidal staining – CS) in ICG (figure 9). CS was also observed in 14 affected 
eyes (93,4%) in the non-active sites of the retina usually around the peripappillary area and in the 
posterior pole (figure 10). Also CS was evident in the fellow eyes in 73,3% (11 eyes, figure 10). 
This was not observed in the classical fluorescein angiography in any of the cases.  
A detailed presentation of FA and ICG findings is displayed in tables 7 and 8. 
 
 
 
Figure 7. 
ICG angiography in PEDs displayed an even fluorescence in the early phases 
followed by a gradual  
fainting in the central portrion, leaving at the end of the examination a 
hypefluorescent border. The first picture is the FA of a patient with active CSC 
and PEDs while the other two pictures are the ICG angiograms of the same 
patient. The fourth picture is from the ICG angiogram of another patient in the 
late phase showing the hypefluorescence around the borders of a PED.  
FA 
ICG – late phase 
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Figure 8. 
In the late phases of ICG angiograms, the dye showed at the site of the leakage a hyperfluorescent spot at the level of RPE together with a 
diffuse staining of the subretinal fluid. Fluorescein and ICG displayed almost an identical pattern of dye diffusion. The dye did not 
covered all the detached area of the neurosensory retina.
Figure 9. 
All the affected eyes in patients with active CSC showed an area of choroidal hyperfluorescence in the ICG angiogram (choroidal 
staining, CS). In this figure we present two ICG angiograms of patients with active CSC. In the left picture multiple lesions of choroidal 
staining (CS) are presented in the affected eye, while a solitary lesion of CS is displayed in the fellow eye. The lesions of CS in ICG 
angiography in CSC patients are usually multiple and scaterred around posterior pole and/or around the optic disc.  
FA I
CG
ICG 
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Figure 10. 
Choroidal staining was also observed in the affected eyes in the non-active sites of the retina (white arrows, 93.4%) usually around 
the peripappilary area and throughout the posterior pole. CS was additionally recorded in the fellow eyes in 73,3%(black arrows). 
This was not observed in the FA angiogram. Both FA and ICG angiograms are displayed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FA 
ICG 
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Endpoint of follow-up: Reccurences in the group of patients with acute CSC after the initial 
episode were recorded only in 5 eyes (22,72%). Using FA the reccurences were observed at the 
same eye and the POD or PODs were at the same site of the retina. No additional PODs, or a POD 
at a different site of the retina were recorded in FA. 
All the eyes with reccurences subside without any other complication, and visual acuity returned 
to baseline levels. 
PEDs at the end of observation were not recorded using FA. 
The number of eyes with PEA in FA is greater in the affected eyes at the endpoint when 
compared with the baseline (66,8% vs 86,7%). In the fellow eyes this difference was not recorded 
with regard PEA. 
The ICG findings at the end of follow-up period are mainly focused on the choroidal staining 
(CS). The frequency of CS is diminished at the end of observation when compared with the baseline 
frequency (see table 8). 
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Table 7. Fluorescein angiography findings of the patients with acute CSC at the baseline and at the 
end of follow-up period (15 patients, 15 eyes, * d.d= disc diameter). 
 
 
Fluorescein angiography findings Baseline End of follow-up
1) Point or points of diffusion - POD 
- number of eyes 15 eyes / 100% - 
  1 POD  14 eyes / 93,4% - 
  2 PODs  1 eyes / 6,6% - 
  3 PODs   - 
 
  "smoke-stack" configuration of POD 4 eyes / 26,7% - 
2) Serous Retinal Detachment - SRD 15 eyes / 100% - 
3) Retinal Pigment Epithelial Detachment - PED 
- number of eyes 6 eyes / 40% - 
  1 PED  4 eye / 26,7% - 
  2 PEDs  2 eyes / 13,4% - 
- number of eyes with POD on PED 2 eyes / 13,4% - 
 
- number of eyes with bilateral PEDs 2 eyes / 13,4% - 
4) Retinal Pigment Epithelium Alterations - PEA (affected eyes) 
- number of eyes totaly 10 eyes / 66,8% 13 eyes / 86,7% 
  small extend  5 eyes / 33,3% 7 eyes / 46,7% 
  more than 1 d.d* 4 eyes / 26,7% 5 eyes / 33,4% 
 
  like the "tail of a comet" 1 eye / 6,6% 1 eye / 6,6% 
5) Retinal Pigment Epithelium Alterations - PEA (fellow eyes) 
- number of eyes tottaly 12 eyes / 80% 12 eyes / 80% 
  small extend  9 eyes / 60% 9 eyes / 60% 
  more than 1 d.d* 3 eyes / 20% 3 eyes / 20% 
 
  like the "tail of a comet" - - 
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Table 8. Summary of the most important findings in ICG angiography in patients with active CSC at 
the baseline and at the end of follow-up (15 patients, 15 eyes). 
 
 
ICG angiography findings Baseline End of follow-up
1) Subretinal leakage (ICG point of diffusion) - SBRL 
- number of eyes 7 eyes / 46.6% - 
  1 SBRL 7 eyes / 46.6% - 
  2 SBRLs - - 
 
-"smoke pipe" configuration of SBRL 3 eyes / 20% - 
2) Retinal Pigment Epithelial Detachment - PED 
  1 PED  3 eyes / 20% - 
  2 PEDs 2 eyes / 13.4% - 
- number of eyes with SBRL on PED 2 eyes / 13.4% - 
 
- number of eyes with bilateral PEDs 1 eye / 6.7% - 
3) Choroidal Staining - CS (choroidal hyperfluorescence) 
- CS in the active site of the retina (affected eyes) 15 eyes / 100% 11 eyes / 73,4% 
- CS in the non active sites of the retina (affected       
  eyes) 
14 eyes / 93.4% 8 eyes / 53,4% 
 
- CS in the fellow eyes 11 eyes / 73.3% 8 eyes / 53,4% 
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Figure 1. 
This patient had an active form of CSC and 
the classic ‘smoke-stack’ appearance in the 
FA. The ‘comet’ like alterations of the 
retinal pigment epithelium can also be 
observed inferior to the macula. The black 
arrow points to the fluorescein leakage 
while the white arrow to the alterations of 
the retinal pigment epithelium. 
Inactive CSC findings - Changes from baseline to endpoint of follow-up 
Baseline findings: All the eyes (4 eyes, 100%), affected by the inactive form of the disease 
together with the fellow eyes showed alterations of the RPE (figure 11). These PEA were detected 
by clinical examination and fluorescein angiography. Additionally, one eye (50%) displayed PED. 
This PED was solitary in this patient and remained stationary during the observation period . 
Choroidal hyperfluorescence (CS) 
using ICG angiogram was recorded 
in the sites of the retina with 
previous activity (old FA and clinical 
examination) in three eyes (75%) 
while CS was not recorded in the 
sites of the retina without any 
previous activity. CS in the fellow 
eyes was recorded in one eye only 
(25%, figure 11a and 11b). These results are shown in tables 9 and 10. 
Endpoint of follow-up: The above mentioned alterations in FA and ICG angiography remained 
unchanged during all the observation period. All the sites with PEA and the corresponding CS areas 
near or at the sites of PEA did not alter their shape or their size. 
 
 
 
 
 
 
 
 
 
FA Figure 11a. 
In the inactive form 
of the disease all the 
eyes (affected and 
non-affected eyes) 
showed alterations 
of the RPE. These 
alterations of the 
RPE (PEA) were 
detected both by 
clinical examination 
and FA. 
The white arrows 
show the PEA . 
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Table 9. 
Fluorescein angiography findings of the patients with inactive CSC at the baseline and at the end of the 
follow-up period (2 patients, 2 eyes). 
Fluorescein angiography findings Baseline End of follow-up
1) Retinal Pigment Epithelial Detachment - PED 
- number of eyes 1 eye / 50% 1 eye / 50%  
  1 PED 1 eye / 50% 1 eye / 50% 
2) Retinal Pigment Epithelium Alterations - PEA 
- number of eyes totally (affected and fellow eyes) 4 eyes / 100% 4 eyes / 100%  
- small extend  4 eyes / 100% 4 eyes / 100% 
 
* d.d= disc diameter 
 
 
 
 
ICG Figure 11b. 
In the ICG 
angiography the 
eyes (affected and 
non-affected eyes) 
with the inactive 
form of the disease 
showed choroidal 
staining 
(black arrows 
show the CS).  
These areas of CS 
are scattered 
around posterior 
pole and optic disc 
and are mainly 
concentrated in the 
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Table 10. 
ICG findings for the group of inactive CSC patients at the baseline and at the end of the follow-up period (2 
patients, 2 eyes). 
ICG angiography findings Baseline End of follow-up 
1) Retinal Pigment Epithelial Detachment - PED (affected eyes) 
- number of eyes 1 eye / 50% 1 eye / 50%  
  1 PED 1 eye / 50% 1 eye / 50% 
2) Choroidal Staining - CS (choroidal hyperfluorescence) 
- number of eyes totally (affected and fellow eyes) 3 eyes / 75% 3 eyes / 75% 
- CS in the site of the retina with previous activity  
  (History, old FA, PEA) 
2 eyes / 50% 2 eyes / 50% 
- CS in the sites of the retina without any signs of   
  previous activity 
- - 
 
- CS in the fellow eyes 1 eye / 25% 1 eye / 25% 
 
Chronic CSC findings - Changes from baseline to endpoint of follow-up 
Baseline findings: Serous neurosensory retinal detachment was evident using FA in 5 eyes-100% 
(3 patients). In two patients the disease was bilateral (40%). Widespread alterations of the retinal 
pigment epithelium (PEA) were also recorded in all affected eyes (100%) and the fellow eye of one 
patient. In one eye with scarring of the posterior pole, the associated PEAs in this eye resembled 
the “tail of the comet”. PEDs were detected in three eyes (two patients 60%) while bilateral PEDs 
were recorded in one eye only (20%). 
Although 4 PODs were detected at the baseline using FA only 2 PODs were find by ICG 
angiography. The number of the PEDs detected by FA matches that of ICG angiography. Choroidal 
staining (CS) was evident in all the affected eyes (5 eyes-100%) but also in the fellow eye of one 
patient. CS was presented in the vicinity of the active areas of the retina but also in remote areas. 
Scarring of the posterior pole was recorded in one eye (20%). The extent and the shape of the scar 
tissue resembled the findings of the FA. Hypopigmented spots were recorded in none of the eyes at 
the baseline. 
Endpoint of follow-up: Serous retinal detachment was recorded in all patients (5 patients / 
100%). PODSs were detected with FA angiography in two eyes (40%, figure 12). Two PODs were 
detected in one eye (20%, figure 13). In this patient the disease was bilateral. 
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In fellow eye of one of the patients with chronic CSC inactive CSC was evident with multiple scars in 
the macula and diffuse RPE decompensation (figure 14). PEDs were detected in 4 eyes (80%) while 
Figure 12. 
Serous retinal detachment was detected in all the patients 
with the chronic form of CSC. PODs were detected using 
FA in two eyes (40%). The picture shown below is a FA 
from the right eye of a patient with chronic CSC. 
Figure 13. 
Two PODs were detected with the FA in two patients (40%) with 
chronic CSC. In this FA of a patient with chronic CSC two PODs can 
be recognized. A PED is also shown in the contralateral eye. The 
black arrows point to the PODs and the white arrows to the PEDs. 
Figure 14. 
In this figure we display the FA of a patient with chronic CSC. There are multiple scars on the 
macula and a diffuse RPE decompensation. FA was obtained via a Heidelberg retina camera. 
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bilateral PEDs were disclosed in 4 eyes (80%). PEAs were detected in all the eyes of this group (5 
eyes, 100%). In 80% these alterations were extensive occupying large areas of the retina (>1d.d). 
Configuration of these alterations like the ‘tail of a comet’ (more precisely this lesion is termed RPE 
atrophic tracts) was recorded in one eye (20%) (figure 15). A synoptic presentation of the above 
mentioned findings is displayed in table 11. 
 
 
 
 
 
 
 
 
 
 
 
With the aid of ICG angiography no point of diffusion was detected in eyes with chronic CSC. 
Bilateral PEDs were detected in 4 eyes (80%). Choroidal staining was recorded in all affected eyes 
(5 eyes - 100%) of this group and in one fellow eye. CS was detected in the active sites of the 
retina in 5 eyes (100%) while it was detected also in other sites (non active with regard to clinical 
and FA findings) of the retina (5 eyes, 100%). 
In a patient with a more advanced form of the disease there were multiple hypopigmented spots 
in ICG while in the same areas in FA nothing was recorded (figure 15). The same findings in this 
patient were recorded 18 months later when FA and ICG were repeated after the first examination. 
Hypopigmented spots were shown in 4 eyes (80%) and extensive scarring of the posterior pole in 
two eyes (40%). A detailed analysis of these data is shown in table 12. 
Choroidal ischemia or other areas with perfusion defects were not detected clinically and 
angiographically (FA & ICG) in any of the cases of this study during the observation period. 
 
 
 
 
Figure 15. 
The specific configuration of the RPE alterations in the chronic 
form of the disease resulted in a ‘comet-like’ appearance in FA. 
In this figure the FA and ICG of a patient with chronic CSC and 
the above mentioned features are displayed. Additionally 
multiple hypopigmented spots were disclosed using ICG. These 
spots were recorded in the areas of the retina where the FA did 
not show any other finding. 
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Table 11. 
Fluorescein angiography findings at the baseline and at the end of follow-up period of the 
patients with chronic CSC (3 patients, 5 eyes). 
 
 
Fluorescein angiography findings Baseline End of follow-up
1) Serous Retinal Detachment -  SRD 5 eyes / 100% 5 eyes / 100% 
2) Point or points of diffusion - POD 
   1 POD 1 eyes / 20% 1 eye / 20% 
   2 PODs 3 eyes / 60% 1 eye / 20% 
3) Retinal Pigment Epithelial Detachment - PED 
   1 PED 1 eye / 20% 1 eye / 20% 
   2 PEDs 1 eye / 20% 3 eyes / 60% 
 - number of eyes with POD on PED 1 eye / 20% - 
 - number of eyes with bilateral PEDs 1 eye / 20% 2 eyes / 40% 
4) Retinal Pigment Epithelium Alterations - PEA  
    (affected eyes) 
 - small extend  3 eyes / 60% - 
 - more than 1 d.d* 2 eyes / 40% 5 eyes / 100% 
 - like the "tail of a comet" 1 eyes / 20% 1 eyes / 20% 
 - scar tissue on the posterior pole 1 eyes / 20% 1 eyes / 20% 
4) Retinal Pigment Epithelium Alterations - PEA  
    (fellow eyes) 
 - small extend  - - 
 - more than 1 d.d* 1 eye  1 eye  
 - like the "tail of a comet" - - 
 - scar tissue on the posterior pole - 1 eye  
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Table 12. 
Indocyanine green angiography findings of the patients with chronic CSC (3 patients, 5 eyes). 
 
ICG angiography findings Baseline End of follow-up
1) Subretinal leakage (ICG point of diffusion) - SBRL 
   1 SBRL 2 eyes / 40% - 
2) Retinal Pigment Epithelial Detachment - PED 
   1 PED  1 eye / 20% - 
  > 2 PEDs 1 eye / 20% 4 eyes / 80% 
 - number of eyes with SBRL on PED 1 eye / 20% - 
 - number of eyes with bilateral PEDs 1 eye / 20% 4 eyes / 80% 
3) Choroidal Staining - CS  
   (choroidal hyperfluorescence) 
 - CS in the active site of the retina 5 eyes / 100% 5 eyes / 100% 
 - CS in the non active sites of the retina 5 eyes / 100% 5 eyes / 100% 
 - CS in the fellow eyes 1 eye  1 eye  
4) Scaring of the posterior pole 
 - hypopigmented spots - 1 eyes / 20% 
 - extensive scaring 1 eye / 20% 2 eyes / 40% 
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Central serous chorioretinopathy (CSC) is a disease with a very controversial pathogenesis. The 
pathogenesis of CSC is still under discussion [1-11]. In the past, the involvement of the retinal 
pigment epithelium (RPE), rather than of the choroid, appeared to be the critical point in the 
formation of a serous detachment of the neuroepithelium [1,9,12], After its recognition and 
description as a single disease entity by von Graefe [3], the use of FA, initially by Maumenne[4], 
has contributed a lot to the diagnosis of the disease and the follow-up of the patients [1,2,13,14]. 
Fluorescein angiography has also given us the first insights into the pathogenesis of the disease by 
detecting the dye leakage from a defect in the RPE. Although we are able to make the diagnosis 
and to identify one or multiple defects or alterations of the RPE with FA, it is not possible to clarify 
the exact role of RPE and the choroidal vasculature in this disease because of the screening effect 
of the pigment epithelium.  
Using a new fluorescent substance, the indocyanine-green, we were able to observe and record 
images of the choroid during the last 20 years [15,16]. Indocyanine-green is a tricarbocyanide dye, 
with peak absorption at 805 nm and fluorescence emission in the near infrared range (835 nm) [15-
21]. Since the retinal pigment epithelium absorbs only 10% of the infrared radiation used in ICG 
angiography [22], the technique has made it possible to observe choroidal lesions in CSC that 
escape detection by FA. Like many new clinical diagnostic or therapeutic tools in medicine, ICG 
angiography evolved in two basic stages. The first was exploratory in nature and occurred mainly in 
the early 1990s whereas the second stage had begun by the end of 1994. During this stage, the 
investigators started to examine more specifically where and how ICG angiography could be of 
value in clinical practice. The first attempts to visualize the choroid vasculature in the past were 
confined by the inability to obtain high-resolution images. This factor had limited the clinical 
usefulness of ICG angiography. Later the advent of high-resolution ICG angiography images [23,24] 
gave us a new method in the common clinical practice of ophthalmology for the investigation of the 
choroid and thus the exploration of the role of this tissue in the CSC pathogenesis. Choroidal blood 
flow was studied with a specialized digital computer system [25] and also with ICG 
videoangiography and the scanning laser ophthalmoscope [24].  
Although many studies in recent literature have focused their attention on the role of the 
retinal pigment epithelium [9,12], observations with ICG by many authors suggest a primary 
implication of the choroid in CSC [26-30]. The crucial role of the choroidal vasculature was 
hypothesised by a number of authors before ICG angiography became available. Fibrinous choroidal 
deposits were reported by De Venecia [31]. The same findings of fibrinous deposits in cases of CSC 
during pregnancy argue in favour of choroidal exudation [32-35]. Disorders of choroidal perfusion 
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[26,30] and an abnormal choroidal vascular permeability [28,36,29] have been proposed as the 
primary changes in this disease. 
Most of the observations made using indocyanine green angiography in this series of 22 eyes 
with CSC are in accordance with what other authors have already described, particularly with 
regard to the findings of subretinal leakage, choroidal staining and the aspect of pigment epithelial 
detachment. 
Subretinal diffusion of ICG is indicated by the observation of the ‘smoke stack’ lesions, similar 
to those on the FA at the leakage points [26,27,37], and by the staining of the serous 
neuroepithelial detachment (figure 6 and 8). 
While using ICG angiography, numerous authors have observed hyperfluorescent lesions 
which were related to choroidal hyperpermeability, thus giving new support to the hypothesis of 
choroidal implication for CSC pathogenesis. Delayed choroidal perfusion was also recorded [38-40], 
leading to the hypothesis that capillary or venous congestion after an episode of ischemia in one or 
more lobules of the choroid might be the cause of the abnormal choroidal hyperpermeability. 
Hayashi et al [26] and Scheider et al [27] who used ICG videoangiography concluded that CSC 
primarily affects the choroid and proposed that choroidal perfusion defects are the initial lesion of 
the disease. In a similar study Prünte C and Flammer J.[30], used Scanning Laser Ophthalmoscope, 
which allows a dynamic examination of the filling phases. It was evident that in patients with acute 
or chronic CSC there was a capillary or venous congestion of the choroid after a perfusion defect in 
one or more choroidal lobules. On the contrary, none of the patients in the series of Guyer et al. 
[29] showed this future with Topcon Imagenet system, which offers superior images in the middle 
and late phase of the examination. 
Also, in our study we did not observe perfusion defect areas of the choroid probably as a 
result of the imaging system we used. The more precise and sophisticated image analysis used by 
Scheider A [27] and Prünte C [30] provided more detailed information on changes in the choroidal 
microcirculation when compared with the conventional systems for ICG angiography. 
Typical central serous chorioretinopathy usually has a benign prognosis, but some variants 
are considered to be vision-threatening conditions. In our study visual acuity was greatly diminished 
in both eyes in one of our patients after a long period of remisions and exacebrations of the disease 
(patient No 14, Table11-12, figures 12-15). CSC with bullous retinal detachment as reported by 
Gass [41] and others [42-44] is one of the severe variants. It is characterized by shifting subretinal 
fluid, subretinal accumulation of whitish fibrinous deposits, and multiple areas of retinal pigment 
epithelial detachment (PEDs). FA reveals multiple severe dye leaks through the RPE and/or from 
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the PEDs sites. These alterations can also be found in the contralateral eye. Widespread retinal 
pigment epithelial disturbance is another type of severe CSC that has been designated as chronic 
CSC or diffuse retinal pigment epitheliopathy [45] and is similarly referred to by others [46-50]. 
Chronic and recurrent serous detachment of the retina, solitary or multiple PEDs, multiple PEDs, 
multiple fluroscein dye leaks, stippled pigmented and depigmented areas of retinal pigment 
epithelium with or without oozing of fluroscein dye leakage, tracts of atrophic RPE, and bilateral 
involvement have been noted in this condition. The chronic and progressive nature of pigmnet 
epithelial alterations leads to poor visual prognosis [14,46,47,49-52]. These variants are not 
mutually exclusive, and a severe form of CSC may show characteristics of both types [53]. 
Although recurrence of CSC may possibly be related to frequent episodes of emotional stress 
and/or the patient’s character (type A personality) [54], such recurrence and its chronicity suggest 
that an ophthalmoscopically undetectable pathology might have persisted for a long period. 
The correspondence of the point of dye leakage between ICG and FA in our study was 
46.6% in the active CSC while no point of diffusion was detected with ICG in the chronic form. 
Fluorescein angiography revealed the point of leakage in all the cases of active CSC. On the 
contrary the ICG failed to demonstrate the leaking point in 8 eyes of patients with active CSC and 
did not show any additional leaking point. This finding is in accordance with the studies of Hayashi 
et al (80%) [26] and Scheider et al (79%) [27] who found lesser capability of ICG to detect PODs. 
These PODs appeared in ICG angiography as hypefluorescent spots during the early minutes of the 
examination (figure 9) and in the middle period, they were surrounded by a more extensive 
hyperfluorescence due to choroidal staining, with which the spots sometimes merged (figure 8 and 
9). Hyperfluorescence of PODs persisted until the late stages (30-60 minutes) when it was more 
clearly defined because choroidal staining gradually faded (figure 9).  
The other more striking feature of ICG angiography in this disease was the presence of 
hyperfluorescence of the choroid (choroidal staining) in the areas surrounding the leaking point. 
Also choroidal staining was recorded in other areas the boundaries of which were independent of 
those of neurosensory retinal detachment, sometimes associated with pigment epithelium atrophy 
and in the majority of the cases these areas had no FA alterations (figures 7,9,10,11). This 
hyperfluorescence was also recorded in the majority of the fellow eyes of the patients with the 
different forms of the disease (active, chronic, inactive. See table 7-12). These areas of 
hyperfluorescence are analogous to those described by Scheider et al.[27], Cardillo, Piccolino and 
Borgia [37] and Guyer et al.[29]. The ICG dye passes to the subepithelial space and to the 
subretinal space through a RPE defect. Passing through a defect of the RPE presuppose diffusion of 
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the dye into the choroid. The molecule of the ICG is almost completely bound to plasma proteins 
(albumin and a1-lipoprotein)[55], so normally it almost exclusively remains in the intravascular 
compartment. This factor together with the high molecular weight of the ICG (775 dalton) are the 
limiting factors that do not permit the passage of the dye through the fenestrated capillaries of the 
choroicapillaris and thus no diffusion in the choroid is observed under normal conditions [56]. 
Nevertheless the dye has the capability to diffuse under certain conditions [57-59]. Bearing all 
these in mind we considered this hyperfluorescence as a sign of abnormal choroidal 
hyperpermeability because ICG does not exude in detectable quantities in the normal choroid [56]. 
This choroidal hyperfluorescent or choroidal staining seems to be characteristic of this disorder 
[29,36,37]. Areas of CS due to presumed choroidal permeability appeared after 5-10 minutes and 
tended to diminish in intensity after 30-40 minutes, often growing larger as described by Cardillo 
Piccolino and Borgia [36,37]. Following 15 to 30 minutes after initiation of ICG examination CS 
reached its peak intensity, the large choroidal vessels often appeared as hypofluorescent streaks 
within hyperfluorescent areas (figure 15), which Spaide et al.[30] referred to as ‘silhouetting of 
choroidal vessels’. This observation proves that that ICG may leak from the choriocapillaris and 
reach deep choroidal extravascular spaces. Although choroidal hyperfluorescence gradually spreads 
laterally and fades, it does not necessarily disappear even 60 min after the dye injection. Such 
areas of hyperfluorescent attributable to hyperpermeability of choroidal vessels were found in the 
literature in almost 99% of the eyes with CSC [36,37]. Our study gave the same results when 
compared with previous studies. ICG leakage also appeared in the fellow eyes in the majority of the 
cases where no clinical or FA signs of active disease were present. It was evident from the follow-
up of the eyes with CSC where the disease spontaneously regressed, that the permeability changes 
in the choroid still persisted, even though the RPE leakage points disappeared. Another 
characteristic of these hyperpermeability areas was their distribution that resembled clusters of 
lobules dependent on an arteriole. All of these findings suggest that choroidal vascular 
hyperpermeability may be the fundamental lesion in CSC. In addition, choroidal staining was also 
noted at the sites of PEDs in all our cases of CSC. 
Although the exact mechanism of choroidal staining due to intrachoroidal dye leakage in CSC 
is not clear, it has been attributed to hyperpermeability of the choriocapillaries. This presumed 
hyperpermeability leads to dye diffusion into the extravascular space of the choroid 
[26,27,29,37,56]. Under normal circumstances there is a little leakage of albumin in the choroid 
[72]. Bearing this in mind and the smaller size of the molecule of indocyanine green dye it is very 
possible to postulate that a more extensive leakage exists in the presence of increased permeability 
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of the choriocapillaries. Choroidal hyperpermeability hypothesis is also supported by the 
accumulation of fibrin under the retina in certain cases of CSC. Exudation of fibrinogen suggests 
that the choriocapillaris could become sufficiently hyperpermeable [57]. Fluroscein-dye leakage in 
this study and the other related studies [26,27,29,37,34] in the literature tended to be recorded at 
or near the sites of intrachoroidal dye leakage (choroidal staining) on ICG angiography. This 
anatomical corellation sugests hyperperfusion and subsequent stress leading to hyperpermeability 
of the choriocapillaries is possible at these sites [36,37]. Alternatively delayed arterial filling 
(hypoperfusion) followed by congestion of choroidal capillaries and venules [30] may produce some 
disturbance in the choriocapillaries and retinal pigment epithelium. These events lead to fluid 
accumulation beneath the retinal pigment epithelium with a subsequent PED[36,37], impairment of 
the outer blood retinal barrier which corresponds to FA leakage, and malfunction of the retinal 
pigment epithelium causing serous retinal detachment of the retina [58,59,60].  
Another issue regarding this anatomical relationship between intrachoroidal dye leakage and 
FA dye leakage is that during the observation time of the different forms of CSC the intrachoroidal 
leakage persists in the same areas in the majority of the patients. Although some authors 
characterized this finding as a ‘static nature’ of CS it is evident that this phenomenon has a dynamic 
feature. In some of our patients CS faded during a long follow-up and the size also diminished. The 
‘static nature’ of CS may explain the recurrences of CSC, and the chronicity of the disease that may 
lead to RPE decompensation, scarring, choroidal neovascularization and subsequently the severe 
decrease in visual acuity. The above mentioned observation about the ‘static nature’ of choroidal 
hyperpermeability may also explain the persistent functional impairment of the retina as it was 
found by multifocal electroretinogram (ERG) in patients with CSC after the resolution of subretinal 
fluid [61]. In this study it is suggested that the inner retinal functions were affected subclinically. 
Taking all these into account we can consider CSC a chronic disease with remissions and 
exacerbations that is not only affecting the outer retina in the macula but also the inner layers.  
Another finding on ICG angiograms in eyes with CSC is the appearance of PEDs. The 
frequency of appearance in this study is 40% in acute CSC and 80% in the chronic form. Gyer et 
al.[58] reported PEDs in 75% of the cases with acute CSC and in 85% of the cases with chronic 
CSC. These authors also noticed that many of the lesions were not detected by biomicroscopy or 
FA. (presumed ‘ocult’ pigment epithelial detachments). Pigment epithelial detachments of CSC are 
diffusely stained by the dye in the early phases and subsequently lose their hyperfluprescence 
gradually and become hypofluorescent (see figure 7). Dye residues stain the margin of the PEDs 
and this ring of hyperfluorescence remains through the late phases of angiography. This pattern of 
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dye diffusion in PEDs, and in the areas of choroidal hyperfluorescence is suggestive of a rapid 
turnover of the plasmatic proteins in the extravascular space of the choroid. We know from the Fick 
principle that the local blood flow of a tissue is proportional to the time taken to remove a 
substance from this tissue. Assuming this law together with the ICG findings (hyperfluorescence – 
wash-out phenomenon) we can propose that there is a choroidal hyperperfusion corresponding to 
these areas. 
Another advandage of the ICG angiography is that it can recognise some of the smallest 
PEDs that can not be visualized with FA [36,62]. In cases where there is a PED under subretinal 
fibrinous deposits, there is severe ICG-dye leakage into the subretinal space [63]. The exudation of 
a fibrinogen-like substance supports the hyperpermeability of the choriocapillaries under the PEDs. 
Picolino et al [36] postulated that hyperpermeability of the choriocapillaries corresponded to focal 
choroidal hyperperfusion which could produce PED in CSC. However as it is evident from our cases 
and from other studies [63] the regression of PED is not followed with intrachoroidal ICG-dye 
dissapearance. In the light of these findings we can suppose that other factors apart from the 
hyperpermeability status of the choriocapillaries are necessary so that PED ensues. 
Hypopigmented spots in ICG angiography were recorded in 80% of the cases with chronic 
CSC in our study. These hypopigmented spots corresponded to areas of RPE alterations (figure 15). 
Less frequently these hypo-spots on ICG corresponded to hyperpigmentation or hypertrophy of the 
RPE [64]. During ICG angiography, these hypofluorescent lesions appeared in the middle phases 
and became more distinct after 30 to 60 minutes (figure 15). The lesion could also be noted in 
areas of choroidal hyperpermeability (figure 15). In some cases it is reported in the literature that 
hypo-spots do not correspond to areas affected in FA [64]. Hypofluorescent lesions in CSC have 
clearly defined edges usually when they are small in size. When they are more extensive the edges 
are not so clearly defined and there is an overlapping with areas affected by irregular atrophic 
lesions of the RPE in FA [64]. 
In one case of a patient with chronic CSC we noted a discrete configuration of the RPE 
alterations resembling the ‘tail of a comet’ (figures 14 and 15). This peculiar alteration of the RPE is 
more presicely named ‘RPE atrophic tract’. This term is more widely accepted because it also 
defines the alterations of the RPE caused by chronic inferior shifting of subretinal fluid [64]. 
In a recent article by U.Menchini et al.[64] the angiographic features (FA and ICG) of these 
tracts displayed two patterns. The first pattern is characterized by progressive homogenous 
hyperfluorescence in ICG angiography corresponding to low or absent hyperfluorescence caused by 
a window defect in FA. In an early stage where RPE has limited atrophy, the tract in ICG 
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angiography is hyperfluorescent due to subretinal diffusion of ICG corresponding to the 
neuroepithelial detachment. Subretinal diffusion of ICG can occur through the leak at the posterior 
pole which causes the tract, but possibly also through the initially altered RPE within the tract. This 
configuration is described for tracts in the early stages of development. No such pattern was 
recorded in our study. 
The second pattern is presented with progressive hypofluorescence with ICG angiography 
corresponding to marked atrophy of the RPE with characteristics similar to the late hypofluorescent 
lesions described above (figure 15). This configuration is observed in a later stage of the disease 
when there is marked atrophy of the RPE. The hyperfluorescence in ICG angiography is replaced by 
hypofluorescence due to advance damage to the RPE. Using Heidelberg Retinal tomography we 
were able to see in detail this pattern of atrophic tract in one patient with chronic CSC. 
In conclusion our study supports the hypothesis that had been proposed in 1967 by Gass [2] 
that choroidal exudation precedes REP alteration in CSC. Other authors have also recently 
supported this hypothesis [27,29,37]. Although the FA gives us the point or the points of leakage, 
these findings are not enough to explain the formation of subretinal fluid. We know that after a 
successful retinal detachment surgery the remaining subretinal fluid can be absorbed in a few days 
while as far as the eyes affected with CSC are concerned the fluid persists for many days. This 
factor and other experimental studies suggest that there is not a focal REP impairment but a more 
generalized alteration of the REP around the focal leakage [10,11]. This generalized alteration of 
the transport function of the REP together with the focal point of leakage could be a logical 
explanation for the accumulation of suretinal fluid. A functional alteration of the RPE may be 
expected in the areas where ICG shows permeability alterations of choroidal vasculature. Since ICG 
is bound to proteins, ICG visualizes the passage and turnover of plasma proteins into the subretinal 
space. This is indicative of high protein concentration in the subretinal fluid, which together with 
RPE alterations diminishes the gradient of colloid osmotic pressure between the two sides of the 
RPE that drives the fluid out of the subretinal space and as a result slows down the rate of fluid 
reabsorption.  
The persistence of the choroidal hyperfluorescence after the resolution of the serous 
detachment is a factor that can be implicated in the recurrence of the disease and the progrressive 
alterations of the RPE over the years [14]. The finding of hyperfluorescence spots on ICG in one 
patient with chronic CSC may represent a late stage of macular changes due to long standing CSC. 
Similar results have been reported by Spaide et al [65]. Also the appearance of hyperpermeability 
areas in the fellow eyes suggests a more generalized vascular alteration of the choroid. Recently 
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the activity of a sympathetic nervous system was studied using power spectral analysis in patients 
with CSC [66]. This study showed an increased sympathetic action of the autonomous nervous 
system that probably affect the choroidal circulation [66]. 
The present study is purely clinical. A possible drawback of this may be that no experimental 
data is given, which could enhance the angiographic clues about the pathogenesis of CSC. 
However, an experimental aspect was beyond the purpose of the study. Moreover, although in 
many eye diseases there are numerous corresponding experimental studies, searching of the 
literature for experimental CSC disclosed only limited results, produced mainly by two research 
groups [9, 67-72]. This may be due to the fact that the proposed model of experimental CSC, i.e by 
repeated i.v. injections of adrenaline, cannot create all forms of CSC, is basically a model of central 
serous retinal detachment with a healthy peripheral RPE, is not chronic, and it specifically aims to 
examine the histopathologic changes as well as the dynamics of the choroidal and retinal fluids in 
the presence of RPE defects. For the above reasons, and as we wanted to focus on the ICG-
angiographic abnormalities in patients with CSC, we decided not to include experimental data in the 
present study, but to set the frame for a future synthetic analysis on this issue. 
As we can see from the current literature and from the results of our study, although the 
CSC is classified in acute, chronic and inactive form, the problem is much more complicated. The 
application of the routine clinical examination and/or fluorescein angiogaphy although makes the 
diagnosis in CSC patients is not capable to detect the signs of chronic activity. This overlooked 
activity of the disease revealed by ICG angiography, is possibly the cause of the chronicity and 
recurrence of serous retinal detachment together with the extensive RPE alterations in CSC, in 
particular its severe forms. In the acute forms the disease often reccurs and the prognosis is quite 
good, with regard the visual acuity. On the contrary the prognosis regarding the final visual acuity 
in chronic cases is worse and in some cases may destroy the macula leading to blidness. Despite 
the benign course of the disease in cases with a resolved acute CSC, it is evident using imaging 
with high-resolution OCT that the fovea has a number of morphologic changes even in cases with 
relatively good visual acuity [73]. 
The acute and self-limited condition is the one extremity while the other is probably the 
chronic form of the disease that occasionally may be a sight-threatening disease. The long duration 
of the disease combined with areas of multiple PEDs located in the macula and/or confluent RPE 
atrophy, may lead to severe decrease in visual acuity.  
We believe that ICG angiography is a valuable method for clinical evaluation of the CSC and 
also help us to understand better the pathogenesis of this peculiar disorder. The interpretations 
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however still remain hypothetical. Further work on choroidal hemodynamics and morphology is 
necessary to clarify many aspects and controversies in patients with CSC. At present, ICG 
angiography is of interest mainly for the opportunity it offers to study the choroidal alteration in the 
course of the disease. 
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